A reaction that severs one of the sugar-phosphate linkages of the phosphodiester backbone of RNA. It is catalyzed enzymatically, chemically, or by radiation. Cleavage may be exonucleolytic, or endonucleolytic.
A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
A family of enzymes that catalyze the endonucleolytic cleavage of RNA. It includes EC 3.1.26.-, EC 3.1.27.-, EC 3.1.30.-, and EC 3.1.31.-.
RNA that has catalytic activity. The catalytic RNA sequence folds to form a complex surface that can function as an enzyme in reactions with itself and other molecules. It may function even in the absence of protein. There are numerous examples of RNA species that are acted upon by catalytic RNA, however the scope of this enzyme class is not limited to a particular type of substrate.
Ribonucleic acid that makes up the genetic material of viruses.
Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape.
Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein.
The most abundant form of RNA. Together with proteins, it forms the ribosomes, playing a structural role and also a role in ribosomal binding of mRNA and tRNAs. Individual chains are conventionally designated by their sedimentation coefficients. In eukaryotes, four large chains exist, synthesized in the nucleolus and constituting about 50% of the ribosome. (Dorland, 28th ed)
Molecules of DNA that possess enzymatic activity.
A multicomponent, ribonucleoprotein complex comprised of one of the family of ARGONAUTE PROTEINS and the "guide strand" of the one of the 20- to 30-nucleotide small RNAs. RISC cleaves specific RNAs, which are targeted for degradation by homology to these small RNAs. Functions in regulating gene expression are determined by the specific argonaute protein and small RNA including siRNA (RNA, SMALL INTERFERING), miRNA (MICRORNA), or piRNA (PIWI-INTERACTING RNA).
The ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm.
A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE).
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis.
RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms.
Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-.
Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992).
A gene silencing phenomenon whereby specific dsRNAs (RNA, DOUBLE-STRANDED) trigger the degradation of homologous mRNA (RNA, MESSENGER). The specific dsRNAs are processed into SMALL INTERFERING RNA (siRNA) which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. DNA METHYLATION may also be triggered during this process.
A ribonuclease that specifically cleaves the RNA moiety of RNA:DNA hybrids. It has been isolated from a wide variety of prokaryotic and eukaryotic organisms as well as RETROVIRUSES.
A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
The extent to which an RNA molecule retains its structural integrity and resists degradation by RNASE, and base-catalyzed HYDROLYSIS, under changing in vivo or in vitro conditions.
An endoribonuclease that is specific for double-stranded RNA. It plays a role in POST-TRANSCRIPTIONAL RNA PROCESSING of pre-RIBOSOMAL RNA and a variety of other RNA structures that contain double-stranded regions.
An enzyme that catalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3'-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2',3'-cyclic phosphate intermediates. EC 3.1.27.5.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.
A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
RNA transcripts of the DNA that are in some unfinished stage of post-transcriptional processing (RNA PROCESSING, POST-TRANSCRIPTIONAL) required for function. RNA precursors may undergo several steps of RNA SPLICING during which the phosphodiester bonds at exon-intron boundaries are cleaved and the introns are excised. Consequently a new bond is formed between the ends of the exons. Resulting mature RNAs can then be used; for example, mature mRNA (RNA, MESSENGER) is used as a template for protein production.
The process of cleaving a chemical compound by the addition of a molecule of water.
Ribonucleic acid in fungi having regulatory and catalytic roles as well as involvement in protein synthesis.
Constituent of the 60S subunit of eukaryotic ribosomes. 28S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.
The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction.
The parts of a macromolecule that directly participate in its specific combination with another molecule.
Transcription factors that form transcription initiation complexes on DNA, bind to specific DNA-DIRECTED RNA POLYMERASES and are required to initiate transcription. Although their binding may be localized to distinct sequence and structural motifs within the DNA they are considered non-specific with regard to the specific gene being transcribed.
The rate dynamics in chemical or physical systems.
A family of RNA-binding proteins that has specificity for MICRORNAS and SMALL INTERFERING RNA molecules. The proteins take part in RNA processing events as core components of RNA-induced silencing complex.
Transcription factors whose primary function is to regulate the rate in which RNA is transcribed.
A reaction that severs one of the covalent sugar-phosphate linkages between NUCLEOTIDES that compose the sugar phosphate backbone of DNA. It is catalyzed enzymatically, chemically or by radiation. Cleavage may be exonucleolytic - removing the end nucleotide, or endonucleolytic - splitting the strand in two.
Viruses whose genetic material is RNA.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
Macromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES.
A group of adenine ribonucleotides in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
The processes of RNA tertiary structure formation.
Pairing of purine and pyrimidine bases by HYDROGEN BONDING in double-stranded DNA or RNA.
Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.
The earliest developmental stage of a fertilized ovum (ZYGOTE) during which there are several mitotic divisions within the ZONA PELLUCIDA. Each cleavage or segmentation yields two BLASTOMERES of about half size of the parent cell. This cleavage stage generally covers the period up to 16-cell MORULA.
A family of proteins that promote unwinding of RNA during splicing and translation.
The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for VIRUS CULTIVATION and antitumor drug screening assays.
RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.
The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
The level of protein structure in which combinations of secondary protein structures (alpha helices, beta sheets, loop regions, and motifs) pack together to form folded shapes called domains. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Small proteins usually consist of only one domain but larger proteins may contain a number of domains connected by segments of polypeptide chain which lack regular secondary structure.
The small RNA molecules, 73-80 nucleotides long, that function during translation (TRANSLATION, GENETIC) to align AMINO ACIDS at the RIBOSOMES in a sequence determined by the mRNA (RNA, MESSENGER). There are about 30 different transfer RNAs. Each recognizes a specific CODON set on the mRNA through its own ANTICODON and as aminoacyl tRNAs (RNA, TRANSFER, AMINO ACYL), each carries a specific amino acid to the ribosome to add to the elongating peptide chains.
Positively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis.
Short chains of RNA (100-300 nucleotides long) that are abundant in the nucleus and usually complexed with proteins in snRNPs (RIBONUCLEOPROTEINS, SMALL NUCLEAR). Many function in the processing of messenger RNA precursors. Others, the snoRNAs (RNA, SMALL NUCLEOLAR), are involved with the processing of ribosomal RNA precursors.
The degree of similarity between sequences of amino acids. This information is useful for the analyzing genetic relatedness of proteins and species.
Proteins prepared by recombinant DNA technology.
RNA which does not code for protein but has some enzymatic, structural or regulatory function. Although ribosomal RNA (RNA, RIBOSOMAL) and transfer RNA (RNA, TRANSFER) are also untranslated RNAs they are not included in this scope.
The region of an enzyme that interacts with its substrate to cause the enzymatic reaction.
Nucleic acid structures found on the 5' end of eukaryotic cellular and viral messenger RNA and some heterogeneous nuclear RNAs. These structures, which are positively charged, protect the above specified RNAs at their termini against attack by phosphatases and other nucleases and promote mRNA function at the level of initiation of translation. Analogs of the RNA caps (RNA CAP ANALOGS), which lack the positive charge, inhibit the initiation of protein synthesis.
Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503)
A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques.
A multistage process that includes cloning, physical mapping, subcloning, sequencing, and information analysis of an RNA SEQUENCE.
A sequence of amino acids in a polypeptide or of nucleotides in DNA or RNA that is similar across multiple species. A known set of conserved sequences is represented by a CONSENSUS SEQUENCE. AMINO ACID MOTIFS are often composed of conserved sequences.
Ribonucleic acid in plants having regulatory and catalytic roles as well as involvement in protein synthesis.
A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
Established cell cultures that have the potential to propagate indefinitely.
A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement.
A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.
Ribonucleic acid in protozoa having regulatory and catalytic roles as well as involvement in protein synthesis.
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.
Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility.
An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293)
An enzyme that catalyzes the conversion of linear RNA to a circular form by the transfer of the 5'-phosphate to the 3'-hydroxyl terminus. It also catalyzes the covalent joining of two polyribonucleotides in phosphodiester linkage. EC 6.5.1.3.
RNA present in neoplastic tissue.
The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Proteins obtained from the species SACCHAROMYCES CEREVISIAE. The function of specific proteins from this organism are the subject of intense scientific interest and have been used to derive basic understanding of the functioning similar proteins in higher eukaryotes.
A large family of RNA helicases that share a common protein motif with the single letter amino acid sequence D-E-A-D (Asp-Glu-Ala-Asp). In addition to RNA helicase activity, members of the DEAD-box family participate in other aspects of RNA metabolism and regulation of RNA function.
Small kinetoplastid mitochondrial RNA that plays a major role in RNA EDITING. These molecules form perfect hybrids with edited mRNA sequences and possess nucleotide sequences at their 5'-ends that are complementary to the sequences of the mRNA's immediately downstream of the pre-edited regions.
A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II. EC 2.7.7.6.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
Factors that are involved in directing the cleavage and POLYADENYLATION of the of MESSENGER RNA near the site of the RNA 3' POLYADENYLATION SIGNALS.
Constituent of the 40S subunit of eukaryotic ribosomes. 18S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.
A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. The enzyme functions in the nucleolar structure and transcribes DNA into RNA. It has different requirements for cations and salts than RNA polymerase II and III and is not inhibited by alpha-amanitin. EC 2.7.7.6.
RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm.
A family of intracellular CYSTEINE ENDOPEPTIDASES that play a role in regulating INFLAMMATION and APOPTOSIS. They specifically cleave peptides at a CYSTEINE amino acid that follows an ASPARTIC ACID residue. Caspases are activated by proteolytic cleavage of a precursor form to yield large and small subunits that form the enzyme. Since the cleavage site within precursors matches the specificity of caspases, sequential activation of precursors by activated caspases can occur.
The sum of the weight of all the atoms in a molecule.
Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.
A proprotein convertase with specificity for the proproteins of PROALBUMIN; COMPLEMENT 3C; and VON WILLEBRAND FACTOR. It has specificity for cleavage near paired ARGININE residues that are separated by two amino acids.
Protein precursors, also known as proproteins or prohormones, are inactive forms of proteins that undergo post-translational modification, such as cleavage, to produce the active functional protein or peptide hormone.
Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis.
Constituent of 50S subunit of prokaryotic ribosomes containing about 3200 nucleotides. 23S rRNA is involved in the initiation of polypeptide synthesis.
The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion.
The steps that generate the 3' ends of mature RNA molecules. For most mRNAs (RNA, MESSENGER), 3' end processing referred to as POLYADENYLATION includes the addition of POLY A.
ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA.
Small, linear single-stranded RNA molecules functionally acting as molecular parasites of certain RNA plant viruses. Satellite RNAs exhibit four characteristic traits: (1) they require helper viruses to replicate; (2) they are unnecessary for the replication of helper viruses; (3) they are encapsidated in the coat protein of the helper virus; (4) they have no extensive sequence homology to the helper virus. Thus they differ from SATELLITE VIRUSES which encode their own coat protein, and from the genomic RNA; (=RNA, VIRAL); of satellite viruses. (From Maramorosch, Viroids and Satellites, 1991, p143)
The process of moving specific RNA molecules from one cellular compartment or region to another by various sorting and transport mechanisms.
Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.
Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES.
The small RNAs which provide spliced leader sequences, SL1, SL2, SL3, SL4 and SL5 (short sequences which are joined to the 5' ends of pre-mRNAs by TRANS-SPLICING). They are found primarily in primitive eukaryotes (protozoans and nematodes).
Ribonucleic acid in archaea having regulatory and catalytic roles as well as involvement in protein synthesis.
Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed)
Deoxyribonucleic acid that makes up the genetic material of viruses.
Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis.
Cleavage of proteins into smaller peptides or amino acids either by PROTEASES or non-enzymatically (e.g., Hydrolysis). It does not include Protein Processing, Post-Translational.
A mitochondrial cytochrome P450 enzyme that catalyzes the side-chain cleavage of C27 cholesterol to C21 pregnenolone in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP11A1 gene, catalyzes the breakage between C20 and C22 which is the initial and rate-limiting step in the biosynthesis of various gonadal and adrenal steroid hormones.
A family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.-
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Complexes of RNA-binding proteins with ribonucleic acids (RNA).
Endopeptidases that are specific for AMYLOID PROTEIN PRECURSOR. Three secretase subtypes referred to as alpha, beta, and gamma have been identified based upon the region of amyloid protein precursor they cleave.
Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1.
The complete genetic complement contained in a DNA or RNA molecule in a virus.
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes.
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4.
Enzymes that catalyze the hydrolysis of the internal bonds and thereby the formation of polynucleotides or oligonucleotides from ribo- or deoxyribonucleotide chains. EC 3.1.-.
Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.
Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
Enzymes that catalyze the endonucleolytic cleavage of single-stranded regions of DNA or RNA molecules while leaving the double-stranded regions intact. They are particularly useful in the laboratory for producing "blunt-ended" DNA molecules from DNA with single-stranded ends and for sensitive GENETIC TECHNIQUES such as NUCLEASE PROTECTION ASSAYS that involve the detection of single-stranded DNA and RNA.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesized and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnRNA hybridizes with nuclear DNA rather than with mRNA.
Small nuclear RNAs that are involved in the processing of pre-ribosomal RNA in the nucleolus. Box C/D containing snoRNAs (U14, U15, U16, U20, U21 and U24-U63) direct site-specific methylation of various ribose moieties. Box H/ACA containing snoRNAs (E2, E3, U19, U23, and U64-U72) direct the conversion of specific uridines to pseudouridine. Site-specific cleavages resulting in the mature ribosomal RNAs are directed by snoRNAs U3, U8, U14, U22 and the snoRNA components of RNase MRP and RNase P.
Constituent of the 60S subunit of eukaryotic ribosomes. 5.8S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.
A sub-subclass of endopeptidases that depend on an ASPARTIC ACID residue for their activity.
A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS.
Proteins found in any species of bacterium.
ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism.
Short RNA, about 200 base pairs in length or shorter, that does not code for protein.
Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
Small RNAs found in the cytoplasm usually complexed with proteins in scRNPs (RIBONUCLEOPROTEINS, SMALL CYTOPLASMIC).
Proteins obtained from ESCHERICHIA COLI.
Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
Uridine is a nucleoside, specifically a derivative of pyrimidine, that is composed of a uracil molecule joined to a ribose sugar molecule through a β-N1 glycosidic bond, and has significant roles in RNA synthesis, energy transfer, and cell signaling.
A cell line derived from cultured tumor cells.
The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990)
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
Proteins encoded by a VIRAL GENOME that are produced in the organisms they infect, but not packaged into the VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY.
An RNA-containing enzyme that plays an essential role in tRNA processing by catalyzing the endonucleolytic cleavage of TRANSFER RNA precursors. It removes the extra 5'-nucleotides from tRNA precursors to generate mature tRNA molecules.

Exposure of neurons to excitotoxic levels of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting on RNA 2, and loss of GLUR2 editing. (1/95)

 (+info)

Identification of an hepatitis delta virus-like ribozyme at the mRNA 5'-end of the L1Tc retrotransposon from Trypanosoma cruzi. (2/95)

 (+info)

Structural and functional basis for RNA cleavage by Ire1. (3/95)

 (+info)

Cleavage of rRNA ensures translational cessation in sperm at fertilization. (4/95)

 (+info)

Ribonuclease P. (5/95)

 (+info)

Use of a coenzyme by the glmS ribozyme-riboswitch suggests primordial expansion of RNA chemistry by small molecules. (6/95)

 (+info)

Transcriptional activity regulates alternative cleavage and polyadenylation. (7/95)

 (+info)

miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. (8/95)

 (+info)

RNA cleavage is a biological process in which RNA molecules are cut or split into smaller fragments by enzymes known as ribonucleases (RNases). This process can occur co-transcriptionally, during splicing, or as a means of regulation of RNA stability and function. Cleavage sites are often defined by specific sequences or structures within the RNA molecule. The cleavage products may have various fates, including degradation, further processing, or serving as functional RNA molecules.

RNA (Ribonucleic Acid) is a single-stranded, linear polymer of ribonucleotides. It is a nucleic acid present in the cells of all living organisms and some viruses. RNAs play crucial roles in various biological processes such as protein synthesis, gene regulation, and cellular signaling. There are several types of RNA including messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), small nuclear RNA (snRNA), microRNA (miRNA), and long non-coding RNA (lncRNA). These RNAs differ in their structure, function, and location within the cell.

Endoribonucleases are enzymes that cleave RNA molecules internally, meaning they cut the phosphodiester bond between nucleotides within the RNA chain. These enzymes play crucial roles in various cellular processes, such as RNA processing, degradation, and quality control. Different endoribonucleases recognize specific sequences or structural features in RNA substrates, allowing them to target particular regions for cleavage. Some well-known examples of endoribonucleases include RNase III, RNase T1, and RNase A, each with distinct substrate preferences and functions.

A catalytic RNA, often referred to as a ribozyme, is a type of RNA molecule that has the ability to act as an enzyme and catalyze chemical reactions. These RNA molecules contain specific sequences and structures that allow them to bind to other molecules and accelerate chemical reactions without being consumed in the process.

Ribozymes play important roles in various biological processes, such as RNA splicing, translation regulation, and gene expression. One of the most well-known ribozymes is the self-splicing intron found in certain RNA molecules, which can excise itself from the host RNA and then ligase the flanking exons together.

The discovery of catalytic RNAs challenged the central dogma of molecular biology, which held that proteins were solely responsible for carrying out biological catalysis. The finding that RNA could also function as an enzyme opened up new avenues of research and expanded our understanding of the complexity and versatility of biological systems.

A viral RNA (ribonucleic acid) is the genetic material found in certain types of viruses, as opposed to viruses that contain DNA (deoxyribonucleic acid). These viruses are known as RNA viruses. The RNA can be single-stranded or double-stranded and can exist as several different forms, such as positive-sense, negative-sense, or ambisense RNA. Upon infecting a host cell, the viral RNA uses the host's cellular machinery to translate the genetic information into proteins, leading to the production of new virus particles and the continuation of the viral life cycle. Examples of human diseases caused by RNA viruses include influenza, COVID-19 (SARS-CoV-2), hepatitis C, and polio.

Small interfering RNA (siRNA) is a type of short, double-stranded RNA molecule that plays a role in the RNA interference (RNAi) pathway. The RNAi pathway is a natural cellular process that regulates gene expression by targeting and destroying specific messenger RNA (mRNA) molecules, thereby preventing the translation of those mRNAs into proteins.

SiRNAs are typically 20-25 base pairs in length and are generated from longer double-stranded RNA precursors called hairpin RNAs or dsRNAs by an enzyme called Dicer. Once generated, siRNAs associate with a protein complex called the RNA-induced silencing complex (RISC), which uses one strand of the siRNA (the guide strand) to recognize and bind to complementary sequences in the target mRNA. The RISC then cleaves the target mRNA, leading to its degradation and the inhibition of protein synthesis.

SiRNAs have emerged as a powerful tool for studying gene function and have shown promise as therapeutic agents for a variety of diseases, including viral infections, cancer, and genetic disorders. However, their use as therapeutics is still in the early stages of development, and there are challenges associated with delivering siRNAs to specific cells and tissues in the body.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Nucleic acid conformation refers to the three-dimensional structure that nucleic acids (DNA and RNA) adopt as a result of the bonding patterns between the atoms within the molecule. The primary structure of nucleic acids is determined by the sequence of nucleotides, while the conformation is influenced by factors such as the sugar-phosphate backbone, base stacking, and hydrogen bonding.

Two common conformations of DNA are the B-form and the A-form. The B-form is a right-handed helix with a diameter of about 20 Å and a pitch of 34 Å, while the A-form has a smaller diameter (about 18 Å) and a shorter pitch (about 25 Å). RNA typically adopts an A-form conformation.

The conformation of nucleic acids can have significant implications for their function, as it can affect their ability to interact with other molecules such as proteins or drugs. Understanding the conformational properties of nucleic acids is therefore an important area of research in molecular biology and medicine.

Post-transcriptional RNA processing refers to the modifications and regulations that occur on RNA molecules after the transcription of DNA into RNA. This process includes several steps:

1. 5' capping: The addition of a cap structure, usually a methylated guanosine triphosphate (GTP), to the 5' end of the RNA molecule. This helps protect the RNA from degradation and plays a role in its transport, stability, and translation.
2. 3' polyadenylation: The addition of a string of adenosine residues (poly(A) tail) to the 3' end of the RNA molecule. This process is important for mRNA stability, export from the nucleus, and translation initiation.
3. Intron removal and exon ligation: Eukaryotic pre-messenger RNAs (pre-mRNAs) contain intronic sequences that do not code for proteins. These introns are removed by a process called splicing, where the flanking exons are joined together to form a continuous mRNA sequence. Alternative splicing can lead to different mature mRNAs from a single pre-mRNA, increasing transcriptomic and proteomic diversity.
4. RNA editing: Specific nucleotide changes in RNA molecules that alter the coding potential or regulatory functions of RNA. This process is catalyzed by enzymes like ADAR (Adenosine Deaminases Acting on RNA) and APOBEC (Apolipoprotein B mRNA Editing Catalytic Polypeptide-like).
5. Chemical modifications: Various chemical modifications can occur on RNA nucleotides, such as methylation, pseudouridination, and isomerization. These modifications can influence RNA stability, localization, and interaction with proteins or other RNAs.
6. Transport and localization: Mature mRNAs are transported from the nucleus to the cytoplasm for translation. In some cases, specific mRNAs are localized to particular cellular compartments to ensure local protein synthesis.
7. Degradation: RNA molecules have finite lifetimes and undergo degradation by various ribonucleases (RNases). The rate of degradation can be influenced by factors such as RNA structure, modifications, or interactions with proteins.

Ribosomal RNA (rRNA) is a type of RNA molecule that is a key component of ribosomes, which are the cellular structures where protein synthesis occurs in cells. In ribosomes, rRNA plays a crucial role in the process of translation, where genetic information from messenger RNA (mRNA) is translated into proteins.

Ribosomal RNA is synthesized in the nucleus and then transported to the cytoplasm, where it assembles with ribosomal proteins to form ribosomes. Within the ribosome, rRNA provides a structural framework for the assembly of the ribosome and also plays an active role in catalyzing the formation of peptide bonds between amino acids during protein synthesis.

There are several different types of rRNA molecules, including 5S, 5.8S, 18S, and 28S rRNA, which vary in size and function. These rRNA molecules are highly conserved across different species, indicating their essential role in protein synthesis and cellular function.

Catalytic DNA, also known as deoxyribozyme or DNA enzyme, is a synthetic DNA molecule that has the ability to perform a specific chemical reaction, similar to the function of protein enzymes. These DNA molecules are created in the laboratory through a process called "in vitro selection" or "SELEX" (Systematic Evolution of Ligands by EXponential enrichment), where large populations of random DNA sequences are screened for those that can bind and catalyze a specific chemical reaction.

Once identified, these catalytic DNA molecules can be used for various applications, such as biosensors, gene regulation, and drug delivery. They offer several advantages over traditional protein enzymes, including higher stability under harsh conditions, easier synthesis and modification, and lower immunogenicity. However, their catalytic efficiency is generally lower than that of protein enzymes.

The RNA-induced silencing complex (RISC) is a multiprotein complex that plays a central role in the RNA interference (RNAi) pathway, which is a post-transcriptional gene regulatory mechanism. The RISC complex mediates sequence-specific mRNA degradation or translational repression through the interaction with small non-coding RNAs called small interfering RNAs (siRNAs) or microRNAs (miRNAs).

The siRNAs are double-stranded RNAs that are generated from long, perfectly complementary dsRNA precursors by the enzyme Dicer. Once incorporated into the RISC complex, one strand of the siRNA duplex is removed, and the remaining single-stranded RNA guides the RISC to target mRNAs with complementary sequences. The binding of the RISC-siRNA complex to the target mRNA results in its cleavage or translational repression, leading to gene silencing.

The miRNAs, on the other hand, are single-stranded RNAs that are generated from hairpin precursors by Dicer. Unlike siRNAs, miRNAs typically have imperfect complementarity to their target mRNAs. The RISC-miRNA complex binds to the 3' untranslated region (UTR) of the target mRNA and represses its translation or induces its degradation, depending on the degree of complementarity between the miRNA and the target mRNA.

Overall, the RISC complex is a critical component of the RNAi pathway that plays a crucial role in regulating gene expression at the post-transcriptional level.

RNA splicing is a post-transcriptional modification process in which the non-coding sequences (introns) are removed and the coding sequences (exons) are joined together in a messenger RNA (mRNA) molecule. This results in a continuous mRNA sequence that can be translated into a single protein. Alternative splicing, where different combinations of exons are included or excluded, allows for the creation of multiple proteins from a single gene.

RNA editing is a process that alters the sequence of a transcribed RNA molecule after it has been synthesized from DNA, but before it is translated into protein. This can result in changes to the amino acid sequence of the resulting protein or to the regulation of gene expression. The most common type of RNA editing in mammals is the hydrolytic deamination of adenosine (A) to inosine (I), catalyzed by a family of enzymes called adenosine deaminases acting on RNA (ADARs). Inosine is recognized as guanosine (G) by the translation machinery, leading to A-to-G changes in the RNA sequence. Other types of RNA editing include cytidine (C) to uridine (U) deamination and insertion/deletion of nucleotides. RNA editing is a crucial mechanism for generating diversity in gene expression and has been implicated in various biological processes, including development, differentiation, and disease.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Bacterial RNA refers to the genetic material present in bacteria that is composed of ribonucleic acid (RNA). Unlike higher organisms, bacteria contain a single circular chromosome made up of DNA, along with smaller circular pieces of DNA called plasmids. These bacterial genetic materials contain the information necessary for the growth and reproduction of the organism.

Bacterial RNA can be divided into three main categories: messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA). mRNA carries genetic information copied from DNA, which is then translated into proteins by the rRNA and tRNA molecules. rRNA is a structural component of the ribosome, where protein synthesis occurs, while tRNA acts as an adapter that brings amino acids to the ribosome during protein synthesis.

Bacterial RNA plays a crucial role in various cellular processes, including gene expression, protein synthesis, and regulation of metabolic pathways. Understanding the structure and function of bacterial RNA is essential for developing new antibiotics and other therapeutic strategies to combat bacterial infections.

I'm happy to help! However, it seems there might be a slight misunderstanding in your question. RNA, or ribonucleic acid, is typically single-stranded. Unlike DNA, which is double-stranded and forms a double helix, RNA usually exists as a single strand of nucleotides.

There are exceptions to this rule, such as certain types of RNA molecules that can form double-stranded structures in specific contexts. For example:

1. Double-Stranded RNA (dsRNA) viruses: These viruses have genomes made entirely of RNA, which is double-stranded throughout or partially double-stranded. The dsRNA viruses include important pathogens such as rotaviruses and reoviruses.
2. Hairpin loops in RNA structures: Some single-stranded RNA molecules can fold back on themselves to form short double-stranded regions, called hairpin loops, within their overall structure. These are often found in ribosomal RNA (rRNA), transfer RNA (tRNA), and messenger RNA (mRNA) molecules.

So, while 'double-stranded RNA' is not a standard medical definition for RNA itself, there are specific instances where RNA can form double-stranded structures as described above.

Ribonucleases (RNases) are a group of enzymes that catalyze the degradation of ribonucleic acid (RNA) molecules by hydrolyzing the phosphodiester bonds. These enzymes play crucial roles in various biological processes, such as RNA processing, turnover, and quality control. They can be classified into several types based on their specificities, mechanisms, and cellular localizations.

Some common classes of ribonucleases include:

1. Endoribonucleases: These enzymes cleave RNA internally, at specific sequences or structural motifs. Examples include RNase A, which targets single-stranded RNA; RNase III, which cuts double-stranded RNA at specific stem-loop structures; and RNase T1, which recognizes and cuts unpaired guanosine residues in RNA molecules.
2. Exoribonucleases: These enzymes remove nucleotides from the ends of RNA molecules. They can be further divided into 5'-3' exoribonucleases, which degrade RNA starting from the 5' end, and 3'-5' exoribonucleases, which start at the 3' end. Examples include Xrn1, a 5'-3' exoribonuclease involved in mRNA decay; and Dis3/RRP6, a 3'-5' exoribonuclease that participates in ribosomal RNA processing and degradation.
3. Specific ribonucleases: These enzymes target specific RNA molecules or regions with high precision. For example, RNase P is responsible for cleaving the 5' leader sequence of precursor tRNAs (pre-tRNAs) during their maturation; and RNase MRP is involved in the processing of ribosomal RNA and mitochondrial RNA molecules.

Dysregulation or mutations in ribonucleases have been implicated in various human diseases, such as neurological disorders, cancer, and viral infections. Therefore, understanding their functions and mechanisms is crucial for developing novel therapeutic strategies.

DNA-directed RNA polymerases are enzymes that synthesize RNA molecules using a DNA template in a process called transcription. These enzymes read the sequence of nucleotides in a DNA molecule and use it as a blueprint to construct a complementary RNA strand.

The RNA polymerase moves along the DNA template, adding ribonucleotides one by one to the growing RNA chain. The synthesis is directional, starting at the promoter region of the DNA and moving towards the terminator region.

In bacteria, there is a single type of RNA polymerase that is responsible for transcribing all types of RNA (mRNA, tRNA, and rRNA). In eukaryotic cells, however, there are three different types of RNA polymerases: RNA polymerase I, II, and III. Each type is responsible for transcribing specific types of RNA.

RNA polymerases play a crucial role in gene expression, as they link the genetic information encoded in DNA to the production of functional proteins. Inhibition or mutation of these enzymes can have significant consequences for cellular function and survival.

RNA interference (RNAi) is a biological process in which RNA molecules inhibit the expression of specific genes. This process is mediated by small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), that bind to complementary sequences on messenger RNA (mRNA) molecules, leading to their degradation or translation inhibition.

RNAi plays a crucial role in regulating gene expression and defending against foreign genetic elements, such as viruses and transposons. It has also emerged as an important tool for studying gene function and developing therapeutic strategies for various diseases, including cancer and viral infections.

Ribonuclease H (RNase H) is an enzyme that specifically degrades the RNA portion of an RNA-DNA hybrid. It cleaves the phosphodiester bond between the ribose sugar and the phosphate group in the RNA strand, leaving the DNA strand intact. This enzyme plays a crucial role in several cellular processes, including DNA replication, repair, and transcription.

There are two main types of RNase H: type 1 and type 2. Type 1 RNase H is found in both prokaryotic and eukaryotic cells, while type 2 RNase H is primarily found in eukaryotes. The primary function of RNase H is to remove RNA primers that are synthesized during DNA replication. These RNA primers are replaced with DNA nucleotides by another enzyme called polymerase δ, leaving behind a gap in the DNA strand. RNase H then cleaves the RNA-DNA hybrid, allowing for the repair of the gap and the completion of DNA replication.

RNase H has also been implicated in the regulation of gene expression, as it can degrade RNA-DNA hybrids formed during transcription. This process, known as transcription-coupled RNA decay, helps to prevent the accumulation of aberrant RNA molecules and ensures proper gene expression.

In addition to its cellular functions, RNase H has been studied for its potential therapeutic applications. For example, inhibitors of RNase H have been shown to have antiviral activity against HIV-1, as they prevent the degradation of viral RNA during reverse transcription. On the other hand, activators of RNase H have been explored as a means to enhance the efficiency of RNA interference (RNAi) therapies by promoting the degradation of target RNA molecules.

Substrate specificity in the context of medical biochemistry and enzymology refers to the ability of an enzyme to selectively bind and catalyze a chemical reaction with a particular substrate (or a group of similar substrates) while discriminating against other molecules that are not substrates. This specificity arises from the three-dimensional structure of the enzyme, which has evolved to match the shape, charge distribution, and functional groups of its physiological substrate(s).

Substrate specificity is a fundamental property of enzymes that enables them to carry out highly selective chemical transformations in the complex cellular environment. The active site of an enzyme, where the catalysis takes place, has a unique conformation that complements the shape and charge distribution of its substrate(s). This ensures efficient recognition, binding, and conversion of the substrate into the desired product while minimizing unwanted side reactions with other molecules.

Substrate specificity can be categorized as:

1. Absolute specificity: An enzyme that can only act on a single substrate or a very narrow group of structurally related substrates, showing no activity towards any other molecule.
2. Group specificity: An enzyme that prefers to act on a particular functional group or class of compounds but can still accommodate minor structural variations within the substrate.
3. Broad or promiscuous specificity: An enzyme that can act on a wide range of structurally diverse substrates, albeit with varying catalytic efficiencies.

Understanding substrate specificity is crucial for elucidating enzymatic mechanisms, designing drugs that target specific enzymes or pathways, and developing biotechnological applications that rely on the controlled manipulation of enzyme activities.

RNA stability refers to the duration that a ribonucleic acid (RNA) molecule remains intact and functional within a cell before it is degraded or broken down into its component nucleotides. Various factors can influence RNA stability, including:

1. Primary sequence: Certain sequences in the RNA molecule may be more susceptible to degradation by ribonucleases (RNases), enzymes that break down RNA.
2. Secondary structure: The formation of stable secondary structures, such as hairpins or stem-loop structures, can protect RNA from degradation.
3. Presence of RNA-binding proteins: Proteins that bind to RNA can either stabilize or destabilize the RNA molecule, depending on the type and location of the protein-RNA interaction.
4. Chemical modifications: Modifications to the RNA nucleotides, such as methylation, can increase RNA stability by preventing degradation.
5. Subcellular localization: The subcellular location of an RNA molecule can affect its stability, with some locations providing more protection from ribonucleases than others.
6. Cellular conditions: Changes in cellular conditions, such as pH or temperature, can also impact RNA stability.

Understanding RNA stability is important for understanding gene regulation and the function of non-coding RNAs, as well as for developing RNA-based therapeutic strategies.

Ribonuclease III, also known as RNase III or double-stranded RNA specific endonuclease, is an enzyme that belongs to the endoribonuclease family. This enzyme is responsible for cleaving double-stranded RNA (dsRNA) molecules into smaller fragments of approximately 20-25 base pairs in length. The resulting fragments are called small interfering RNAs (siRNAs), which play a crucial role in the regulation of gene expression through a process known as RNA interference (RNAi).

Ribonuclease III functions by recognizing and binding to specific stem-loop structures within dsRNA molecules, followed by cleaving both strands at precise locations. This enzyme is highly conserved across various species, including bacteria, yeast, plants, and animals, indicating its fundamental role in cellular processes. In addition to its involvement in RNAi, ribonuclease III has been implicated in the maturation of other non-coding RNAs, such as microRNAs (miRNAs) and transfer RNAs (tRNAs).

Ribonuclease, pancreatic (also known as RNase pancreatica or RNase 1) is a type of enzyme that belongs to the ribonuclease family. This enzyme is produced in the pancreas and is released into the small intestine during digestion. Its primary function is to help break down RNA (ribonucleic acid), which is present in ingested food, into smaller components called nucleotides. This process aids in the absorption of nutrients from the gastrointestinal tract.

Ribonuclease, pancreatic is a single-chain protein with a molecular weight of approximately 13.7 kDa. It has a specific affinity for single-stranded RNA and exhibits endonucleolytic activity, meaning it can cut the RNA chain at various internal points. This enzyme plays an essential role in the digestion and metabolism of RNA in the human body.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

RNA Polymerase II is a type of enzyme responsible for transcribing DNA into RNA in eukaryotic cells. It plays a crucial role in the process of gene expression, where the information stored in DNA is used to create proteins. Specifically, RNA Polymerase II transcribes protein-coding genes to produce precursor messenger RNA (pre-mRNA), which is then processed into mature mRNA. This mature mRNA serves as a template for protein synthesis during translation.

RNA Polymerase II has a complex structure, consisting of multiple subunits, and it requires the assistance of various transcription factors and coactivators to initiate and regulate transcription. The enzyme recognizes specific promoter sequences in DNA, unwinds the double-stranded DNA, and synthesizes a complementary RNA strand using one of the unwound DNA strands as a template. This process results in the formation of a nascent RNA molecule that is further processed into mature mRNA for protein synthesis or other functional RNAs involved in gene regulation.

Oligoribonucleotides are short, synthetic chains of ribonucleotides, which are the building blocks of RNA (ribonucleic acid). These chains typically contain fewer than 20 ribonucleotide units, and can be composed of all four types of nucleotides found in RNA: adenine (A), uracil (U), guanine (G), and cytosine (C). They are often used in research for various purposes, such as studying RNA function, regulating gene expression, or serving as potential therapeutic agents.

RNA precursors, also known as primary transcripts or pre-messenger RNAs (pre-mRNAs), refer to the initial RNA molecules that are synthesized during the transcription process in which DNA is copied into RNA. These precursor molecules still contain non-coding sequences and introns, which need to be removed through a process called splicing, before they can become mature and functional RNAs such as messenger RNAs (mRNAs), ribosomal RNAs (rRNAs), or transfer RNAs (tRNAs).

Pre-mRNAs undergo several processing steps, including 5' capping, 3' polyadenylation, and splicing, to generate mature mRNA molecules that can be translated into proteins. The accurate and efficient production of RNA precursors and their subsequent processing are crucial for gene expression and regulation in cells.

Hydrolysis is a chemical process, not a medical one. However, it is relevant to medicine and biology.

Hydrolysis is the breakdown of a chemical compound due to its reaction with water, often resulting in the formation of two or more simpler compounds. In the context of physiology and medicine, hydrolysis is a crucial process in various biological reactions, such as the digestion of food molecules like proteins, carbohydrates, and fats. Enzymes called hydrolases catalyze these hydrolysis reactions to speed up the breakdown process in the body.

Ribonucleic acid (RNA) is a type of nucleic acid that plays a crucial role in the process of gene expression. There are several types of RNA molecules, including messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA). These RNA molecules help to transcribe DNA into mRNA, which is then translated into proteins by the ribosomes.

Fungi are a group of eukaryotic organisms that include microorganisms such as yeasts and molds, as well as larger organisms like mushrooms. Like other eukaryotes, fungi contain DNA and RNA as part of their genetic material. The RNA in fungi is similar to the RNA found in other organisms, including humans, and plays a role in gene expression and protein synthesis.

A specific medical definition of "RNA, fungal" does not exist, as RNA is a fundamental component of all living organisms, including fungi. However, RNA can be used as a target for antifungal drugs, as certain enzymes involved in RNA synthesis and processing are unique to fungi and can be inhibited by these drugs. For example, the antifungal drug flucytosine is converted into a toxic metabolite that inhibits fungal RNA and DNA synthesis.

28S ribosomal RNA (rRNA) is a component of the large subunit of the eukaryotic ribosome, which is the site of protein synthesis in the cell. The ribosome is composed of two subunits, one large and one small, that come together around an mRNA molecule to translate it into a protein.

The 28S rRNA is a type of rRNA that is found in the large subunit of the eukaryotic ribosome, along with the 5S and 5.8S rRNAs. Together, these rRNAs make up the structural framework of the ribosome and play a crucial role in the process of translation.

The 28S rRNA is synthesized in the nucleolus as a precursor RNA (pre-rRNA) that undergoes several processing steps, including cleavage and modification, to produce the mature 28S rRNA molecule. The length of the 28S rRNA varies between species, but it is typically around 4700-5000 nucleotides long in humans.

Abnormalities in the structure or function of the 28S rRNA can lead to defects in protein synthesis and have been implicated in various diseases, including cancer and neurological disorders.

Catalysis is the process of increasing the rate of a chemical reaction by adding a substance known as a catalyst, which remains unchanged at the end of the reaction. A catalyst lowers the activation energy required for the reaction to occur, thereby allowing the reaction to proceed more quickly and efficiently. This can be particularly important in biological systems, where enzymes act as catalysts to speed up metabolic reactions that are essential for life.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Transcription factors are proteins that play a crucial role in regulating gene expression by controlling the transcription of DNA to messenger RNA (mRNA). When referring to "General Transcription Factors," it indicates a specific group of these proteins that are involved in the basal transcription machinery, which is necessary for the transcription of protein-coding genes in all organisms. These general transcription factors are required for the initiation of transcription and include several conserved components:

1. TFIIA (Transcription Factor II A) - a heterotrimeric complex that binds to the TATA box region of the promoter, enhancing the stability and specificity of the pre-initiation complex.
2. TFIID (Transcription Factor II D) - a multi-subunit complex containing the TATA-binding protein (TBP) and several TBP-associated factors (TAFs). TBP recognizes and binds to the TATA box, while TAFs contribute to promoter recognition, chromatin remodeling, and transcription activation.
3. TFIIB - a single polypeptide that interacts with both TFIID and RNA polymerase II, helping to position the polymerase correctly at the transcription start site.
4. TFIIF - a heterotrimeric complex that stabilizes the interaction between TFIIB and RNA polymerase II, promoting the formation of the pre-initiation complex.
5. TFIIE - a heterodimeric complex that interacts with TFIIB, TFIIF, and RNA polymerase II, playing a role in promoter clearance and the transition from initiation to elongation.
6. TFIIH - a multi-subunit complex containing helicase and kinase activities. It is involved in promoter opening, DNA melting at the transcription start site, and phosphorylation of the C-terminal domain (CTD) of RNA polymerase II to facilitate elongation.

These general transcription factors work together to form a pre-initiation complex that enables RNA polymerase II to initiate transcription accurately and efficiently.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Argonaute proteins are a family of conserved proteins that play a crucial role in the RNA interference (RNAi) pathway, which is a cellular process that regulates gene expression by post-transcriptional silencing of specific mRNAs. In this pathway, Argonaute proteins function as key components of the RNA-induced silencing complex (RISC), where they bind to small non-coding RNAs such as microRNAs (miRNAs) or small interfering RNAs (siRNAs).

The argonaute protein then uses this small RNA guide to recognize and cleave complementary mRNA targets, leading to their degradation or translational repression. Argonaute proteins contain several domains, including the PIWI domain, which possesses endonuclease activity responsible for the cleavage of target mRNAs.

In addition to their role in RNAi, argonaute proteins have also been implicated in other cellular processes, such as DNA damage repair and transposable element silencing. There are eight argonaute proteins in humans (AGO1-4 and AGO6-8), each with distinct functions and expression patterns. Dysregulation of argonaute proteins has been associated with various diseases, including cancer and neurological disorders.

Transcriptional elongation factors are a type of protein involved in the process of transcription, which is the synthesis of an RNA molecule from a DNA template. Specifically, transcriptional elongation factors play a role in the elongation phase of transcription, which is the stage at which the RNA polymerase enzyme moves along the DNA template and adds nucleotides to the growing RNA chain.

These factors help to regulate the speed and processivity of RNA polymerase, allowing for the accurate and efficient production of RNA molecules. They can also play a role in the coordination of transcription with other cellular processes, such as mRNA processing and translation. Some examples of transcriptional elongation factors include the TFIIS complex, SII complex, and elongin. Defects in these factors can lead to abnormalities in gene expression and have been implicated in various diseases, including cancer.

DNA cleavage is the breaking of the phosphodiester bonds in the DNA molecule, resulting in the separation of the two strands of the double helix. This process can occur through chemical or enzymatic reactions and can result in various types of damage to the DNA molecule, including single-strand breaks, double-strand breaks, and base modifications.

Enzymatic DNA cleavage is typically carried out by endonucleases, which are enzymes that cut DNA molecules at specific sequences or structures. There are two main types of endonucleases: restriction endonucleases and repair endonucleases. Restriction endonucleases recognize and cleave specific DNA sequences, often used in molecular biology techniques such as genetic engineering and cloning. Repair endonucleases, on the other hand, are involved in DNA repair processes and recognize and cleave damaged or abnormal DNA structures.

Chemical DNA cleavage can occur through various mechanisms, including oxidation, alkylation, or hydrolysis of the phosphodiester bonds. Chemical agents such as hydrogen peroxide, formaldehyde, or hydrazine can induce chemical DNA cleavage and are often used in laboratory settings for various purposes, such as DNA fragmentation or labeling.

Overall, DNA cleavage is an essential process in many biological functions, including DNA replication, repair, and recombination. However, excessive or improper DNA cleavage can lead to genomic instability, mutations, and cell death.

RNA viruses are a type of virus that contain ribonucleic acid (RNA) as their genetic material, as opposed to deoxyribonucleic acid (DNA). RNA viruses replicate by using an enzyme called RNA-dependent RNA polymerase to transcribe and replicate their RNA genome.

There are several different groups of RNA viruses, including:

1. Negative-sense single-stranded RNA viruses: These viruses have a genome that is complementary to the mRNA and must undergo transcription to produce mRNA before translation can occur. Examples include influenza virus, measles virus, and rabies virus.
2. Positive-sense single-stranded RNA viruses: These viruses have a genome that can serve as mRNA and can be directly translated into protein after entry into the host cell. Examples include poliovirus, rhinoviruses, and coronaviruses.
3. Double-stranded RNA viruses: These viruses have a genome consisting of double-stranded RNA and use a complex replication strategy involving both transcription and reverse transcription. Examples include rotaviruses and reoviruses.

RNA viruses are known to cause a wide range of human diseases, ranging from the common cold to more severe illnesses such as hepatitis C, polio, and COVID-19. Due to their high mutation rates and ability to adapt quickly to new environments, RNA viruses can be difficult to control and treat with antiviral drugs or vaccines.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Genetic transcription is the process by which the information in a strand of DNA is used to create a complementary RNA molecule. This process is the first step in gene expression, where the genetic code in DNA is converted into a form that can be used to produce proteins or functional RNAs.

During transcription, an enzyme called RNA polymerase binds to the DNA template strand and reads the sequence of nucleotide bases. As it moves along the template, it adds complementary RNA nucleotides to the growing RNA chain, creating a single-stranded RNA molecule that is complementary to the DNA template strand. Once transcription is complete, the RNA molecule may undergo further processing before it can be translated into protein or perform its functional role in the cell.

Transcription can be either "constitutive" or "regulated." Constitutive transcription occurs at a relatively constant rate and produces essential proteins that are required for basic cellular functions. Regulated transcription, on the other hand, is subject to control by various intracellular and extracellular signals, allowing cells to respond to changing environmental conditions or developmental cues.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Molecular models are three-dimensional representations of molecular structures that are used in the field of molecular biology and chemistry to visualize and understand the spatial arrangement of atoms and bonds within a molecule. These models can be physical or computer-generated and allow researchers to study the shape, size, and behavior of molecules, which is crucial for understanding their function and interactions with other molecules.

Physical molecular models are often made up of balls (representing atoms) connected by rods or sticks (representing bonds). These models can be constructed manually using materials such as plastic or wooden balls and rods, or they can be created using 3D printing technology.

Computer-generated molecular models, on the other hand, are created using specialized software that allows researchers to visualize and manipulate molecular structures in three dimensions. These models can be used to simulate molecular interactions, predict molecular behavior, and design new drugs or chemicals with specific properties. Overall, molecular models play a critical role in advancing our understanding of molecular structures and their functions.

A genetic template refers to the sequence of DNA or RNA that contains the instructions for the development and function of an organism or any of its components. These templates provide the code for the synthesis of proteins and other functional molecules, and determine many of the inherited traits and characteristics of an individual. In this sense, genetic templates serve as the blueprint for life and are passed down from one generation to the next through the process of reproduction.

In molecular biology, the term "template" is used to describe the strand of DNA or RNA that serves as a guide or pattern for the synthesis of a complementary strand during processes such as transcription and replication. During transcription, the template strand of DNA is transcribed into a complementary RNA molecule, while during replication, each parental DNA strand serves as a template for the synthesis of a new complementary strand.

In genetic engineering and synthetic biology, genetic templates can be manipulated and modified to introduce new functions or alter existing ones in organisms. This is achieved through techniques such as gene editing, where specific sequences in the genetic template are targeted and altered using tools like CRISPR-Cas9. Overall, genetic templates play a crucial role in shaping the structure, function, and evolution of all living organisms.

"Poly A" is an abbreviation for "poly(A) tail" or "polyadenylation." It refers to the addition of multiple adenine (A) nucleotides to the 3' end of eukaryotic mRNA molecules during the process of transcription. This poly(A) tail plays a crucial role in various aspects of mRNA metabolism, including stability, transport, and translation. The length of the poly(A) tail can vary from around 50 to 250 nucleotides depending on the cell type and developmental stage.

RNA folding, also known as RNA structure formation or RNA tertiary structure prediction, refers to the process by which an RNA molecule folds into a specific three-dimensional shape based on its primary sequence. This shape is determined by intramolecular interactions between nucleotides within the RNA chain, including base pairing (through hydrogen bonding) and stacking interactions. The folded structure of RNA plays a crucial role in its function, as it can create specific binding sites for proteins or other molecules, facilitate or inhibit enzymatic activity, or influence the stability and localization of the RNA within the cell.

RNA folding is a complex process that can be influenced by various factors such as temperature, ionic conditions, and molecular crowding. The folded structure of an RNA molecule can be predicted using computational methods, such as thermodynamic modeling and machine learning algorithms, which take into account the primary sequence and known patterns of base pairing and stacking interactions to generate a model of the three-dimensional structure. However, experimental techniques, such as chemical probing and crystallography, are often necessary to validate and refine these predictions.

Base pairing is a specific type of chemical bonding that occurs between complementary base pairs in the nucleic acid molecules DNA and RNA. In DNA, these bases are adenine (A), thymine (T), guanine (G), and cytosine (C). Adenine always pairs with thymine via two hydrogen bonds, while guanine always pairs with cytosine via three hydrogen bonds. This precise base pairing is crucial for the stability of the double helix structure of DNA and for the accurate replication and transcription of genetic information. In RNA, uracil (U) takes the place of thymine and pairs with adenine.

RNA-binding proteins (RBPs) are a class of proteins that selectively interact with RNA molecules to form ribonucleoprotein complexes. These proteins play crucial roles in the post-transcriptional regulation of gene expression, including pre-mRNA processing, mRNA stability, transport, localization, and translation. RBPs recognize specific RNA sequences or structures through their modular RNA-binding domains, which can be highly degenerate and allow for the recognition of a wide range of RNA targets. The interaction between RBPs and RNA is often dynamic and can be regulated by various post-translational modifications of the proteins or by environmental stimuli, allowing for fine-tuning of gene expression in response to changing cellular needs. Dysregulation of RBP function has been implicated in various human diseases, including neurological disorders and cancer.

The cleavage stage of an ovum, also known as a fertilized egg, refers to the series of rapid cell divisions that occur after fertilization. During this stage, the single cell (zygote) divides into multiple cells, forming a blastomere. This process occurs in the fallopian tube and continues until the blastocyst reaches the uterus, typically around 5-6 days after fertilization. The cleavage stage is a critical period in early embryonic development, as any abnormalities during this time can lead to implantation failure or developmental defects.

RNA helicases are a class of enzymes that are capable of unwinding RNA secondary structures using the energy derived from ATP hydrolysis. They play crucial roles in various cellular processes involving RNA, such as transcription, splicing, translation, ribosome biogenesis, and RNA degradation. RNA helicases can be divided into several superfamilies based on their sequence and structural similarities, with the two largest being superfamily 1 (SF1) and superfamily 2 (SF2). These enzymes typically contain conserved motifs that are involved in ATP binding and hydrolysis, as well as RNA binding. By unwinding RNA structures, RNA helicases facilitate the access of other proteins to their target RNAs, thereby enabling the coordinated regulation of RNA metabolism.

HeLa cells are a type of immortalized cell line used in scientific research. They are derived from a cancer that developed in the cervical tissue of Henrietta Lacks, an African-American woman, in 1951. After her death, cells taken from her tumor were found to be capable of continuous division and growth in a laboratory setting, making them an invaluable resource for medical research.

HeLa cells have been used in a wide range of scientific studies, including research on cancer, viruses, genetics, and drug development. They were the first human cell line to be successfully cloned and are able to grow rapidly in culture, doubling their population every 20-24 hours. This has made them an essential tool for many areas of biomedical research.

It is important to note that while HeLa cells have been instrumental in numerous scientific breakthroughs, the story of their origin raises ethical questions about informed consent and the use of human tissue in research.

Antisense RNA is a type of RNA molecule that is complementary to another RNA called sense RNA. In the context of gene expression, sense RNA is the RNA transcribed from a protein-coding gene, which serves as a template for translation into a protein. Antisense RNA, on the other hand, is transcribed from the opposite strand of the DNA and is complementary to the sense RNA.

Antisense RNA can bind to its complementary sense RNA through base-pairing, forming a double-stranded RNA structure. This interaction can prevent the sense RNA from being translated into protein or can target it for degradation by cellular machinery, thereby reducing the amount of protein produced from the gene. Antisense RNA can be used as a tool in molecular biology to study gene function or as a therapeutic strategy to silence disease-causing genes.

Protein biosynthesis is the process by which cells generate new proteins. It involves two major steps: transcription and translation. Transcription is the process of creating a complementary RNA copy of a sequence of DNA. This RNA copy, or messenger RNA (mRNA), carries the genetic information to the site of protein synthesis, the ribosome. During translation, the mRNA is read by transfer RNA (tRNA) molecules, which bring specific amino acids to the ribosome based on the sequence of nucleotides in the mRNA. The ribosome then links these amino acids together in the correct order to form a polypeptide chain, which may then fold into a functional protein. Protein biosynthesis is essential for the growth and maintenance of all living organisms.

Protein binding, in the context of medical and biological sciences, refers to the interaction between a protein and another molecule (known as the ligand) that results in a stable complex. This process is often reversible and can be influenced by various factors such as pH, temperature, and concentration of the involved molecules.

In clinical chemistry, protein binding is particularly important when it comes to drugs, as many of them bind to proteins (especially albumin) in the bloodstream. The degree of protein binding can affect a drug's distribution, metabolism, and excretion, which in turn influence its therapeutic effectiveness and potential side effects.

Protein-bound drugs may be less available for interaction with their target tissues, as only the unbound or "free" fraction of the drug is active. Therefore, understanding protein binding can help optimize dosing regimens and minimize adverse reactions.

Tertiary protein structure refers to the three-dimensional arrangement of all the elements (polypeptide chains) of a single protein molecule. It is the highest level of structural organization and results from interactions between various side chains (R groups) of the amino acids that make up the protein. These interactions, which include hydrogen bonds, ionic bonds, van der Waals forces, and disulfide bridges, give the protein its unique shape and stability, which in turn determines its function. The tertiary structure of a protein can be stabilized by various factors such as temperature, pH, and the presence of certain ions. Any changes in these factors can lead to denaturation, where the protein loses its tertiary structure and thus its function.

Transfer RNA (tRNA) is a type of RNA molecule that plays a crucial role in protein synthesis, the process by which cells create proteins. In protein synthesis, tRNAs serve as adaptors, translating the genetic code present in messenger RNA (mRNA) into the corresponding amino acids required to build a protein.

Each tRNA molecule has a distinct structure, consisting of approximately 70-90 nucleotides arranged in a cloverleaf shape with several loops and stems. The most important feature of a tRNA is its anticodon, a sequence of three nucleotides located in one of the loops. This anticodon base-pairs with a complementary codon on the mRNA during translation, ensuring that the correct amino acid is added to the growing polypeptide chain.

Before tRNAs can participate in protein synthesis, they must be charged with their specific amino acids through an enzymatic process involving aminoacyl-tRNA synthetases. These enzymes recognize and bind to both the tRNA and its corresponding amino acid, forming a covalent bond between them. Once charged, the aminoacyl-tRNA complex is ready to engage in translation and contribute to protein formation.

In summary, transfer RNA (tRNA) is a small RNA molecule that facilitates protein synthesis by translating genetic information from messenger RNA into specific amino acids, ultimately leading to the creation of functional proteins within cells.

Divalent cations are ions that carry a positive charge of +2. They are called divalent because they have two positive charges. Common examples of divalent cations include calcium (Ca²+), magnesium (Mg²+), and iron (Fe²+). These ions play important roles in various biological processes, such as muscle contraction, nerve impulse transmission, and bone metabolism. They can also interact with certain drugs and affect their absorption, distribution, and elimination in the body.

Small nuclear RNA (snRNA) are a type of RNA molecules that are typically around 100-300 nucleotides in length. They are found within the nucleus of eukaryotic cells and are components of small nuclear ribonucleoproteins (snRNPs), which play important roles in various aspects of RNA processing, including splicing of pre-messenger RNA (pre-mRNA) and regulation of transcription.

There are several classes of snRNAs, each with a distinct function. The most well-studied class is the spliceosomal snRNAs, which include U1, U2, U4, U5, and U6 snRNAs. These snRNAs form complexes with proteins to form small nuclear ribonucleoprotein particles (snRNPs) that recognize specific sequences in pre-mRNA and catalyze the removal of introns during splicing.

Other classes of snRNAs include signal recognition particle (SRP) RNA, which is involved in targeting proteins to the endoplasmic reticulum, and Ro60 RNA, which is associated with autoimmune diseases such as systemic lupus erythematosus.

Overall, small nuclear RNAs are essential components of the cellular machinery that regulates gene expression and protein synthesis in eukaryotic cells.

Sequence homology, amino acid, refers to the similarity in the order of amino acids in a protein or a portion of a protein between two or more species. This similarity can be used to infer evolutionary relationships and functional similarities between proteins. The higher the degree of sequence homology, the more likely it is that the proteins are related and have similar functions. Sequence homology can be determined through various methods such as pairwise alignment or multiple sequence alignment, which compare the sequences and calculate a score based on the number and type of matching amino acids.

Recombinant proteins are artificially created proteins produced through the use of recombinant DNA technology. This process involves combining DNA molecules from different sources to create a new set of genes that encode for a specific protein. The resulting recombinant protein can then be expressed, purified, and used for various applications in research, medicine, and industry.

Recombinant proteins are widely used in biomedical research to study protein function, structure, and interactions. They are also used in the development of diagnostic tests, vaccines, and therapeutic drugs. For example, recombinant insulin is a common treatment for diabetes, while recombinant human growth hormone is used to treat growth disorders.

The production of recombinant proteins typically involves the use of host cells, such as bacteria, yeast, or mammalian cells, which are engineered to express the desired protein. The host cells are transformed with a plasmid vector containing the gene of interest, along with regulatory elements that control its expression. Once the host cells are cultured and the protein is expressed, it can be purified using various chromatography techniques.

Overall, recombinant proteins have revolutionized many areas of biology and medicine, enabling researchers to study and manipulate proteins in ways that were previously impossible.

Untranslated regions (UTRs) of RNA are the non-coding sequences that are present in mRNA (messenger RNA) molecules, which are located at both the 5' end (5' UTR) and the 3' end (3' UTR) of the mRNA, outside of the coding sequence (CDS). These regions do not get translated into proteins. They contain regulatory elements that play a role in the regulation of gene expression by affecting the stability, localization, and translation efficiency of the mRNA molecule. The 5' UTR typically contains the Shine-Dalgarno sequence in prokaryotes or the Kozak consensus sequence in eukaryotes, which are important for the initiation of translation. The 3' UTR often contains regulatory elements such as AU-rich elements (AREs) and microRNA (miRNA) binding sites that can affect mRNA stability and translation.

A catalytic domain is a portion or region within a protein that contains the active site, where the chemical reactions necessary for the protein's function are carried out. This domain is responsible for the catalysis of biological reactions, hence the name "catalytic domain." The catalytic domain is often composed of specific amino acid residues that come together to form the active site, creating a unique three-dimensional structure that enables the protein to perform its specific function.

In enzymes, for example, the catalytic domain contains the residues that bind and convert substrates into products through chemical reactions. In receptors, the catalytic domain may be involved in signal transduction or other regulatory functions. Understanding the structure and function of catalytic domains is crucial to understanding the mechanisms of protein function and can provide valuable insights for drug design and therapeutic interventions.

RNA caps are structures found at the 5' end of RNA molecules, including messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA). These caps consist of a modified guanine nucleotide (called 7-methylguanosine) that is linked to the first nucleotide of the RNA chain through a triphosphate bridge. The RNA cap plays several important roles in regulating RNA metabolism, including protecting the RNA from degradation by exonucleases, promoting the recognition and binding of the RNA by ribosomes during translation, and modulating the stability and transport of the RNA within the cell.

Nucleic acid hybridization is a process in molecular biology where two single-stranded nucleic acids (DNA, RNA) with complementary sequences pair together to form a double-stranded molecule through hydrogen bonding. The strands can be from the same type of nucleic acid or different types (i.e., DNA-RNA or DNA-cDNA). This process is commonly used in various laboratory techniques, such as Southern blotting, Northern blotting, polymerase chain reaction (PCR), and microarray analysis, to detect, isolate, and analyze specific nucleic acid sequences. The hybridization temperature and conditions are critical to ensure the specificity of the interaction between the two strands.

Manganese is not a medical condition, but it's an essential trace element that is vital for human health. Here is the medical definition of Manganese:

Manganese (Mn) is a trace mineral that is present in tiny amounts in the body. It is found mainly in bones, the liver, kidneys, and pancreas. Manganese helps the body form connective tissue, bones, blood clotting factors, and sex hormones. It also plays a role in fat and carbohydrate metabolism, calcium absorption, and blood sugar regulation. Manganese is also necessary for normal brain and nerve function.

The recommended dietary allowance (RDA) for manganese is 2.3 mg per day for adult men and 1.8 mg per day for adult women. Good food sources of manganese include nuts, seeds, legumes, whole grains, green leafy vegetables, and tea.

In some cases, exposure to high levels of manganese can cause neurological symptoms similar to Parkinson's disease, a condition known as manganism. However, this is rare and usually occurs in people who are occupationally exposed to manganese dust or fumes, such as welders.

DNA primers are short single-stranded DNA molecules that serve as a starting point for DNA synthesis. They are typically used in laboratory techniques such as the polymerase chain reaction (PCR) and DNA sequencing. The primer binds to a complementary sequence on the DNA template through base pairing, providing a free 3'-hydroxyl group for the DNA polymerase enzyme to add nucleotides and synthesize a new strand of DNA. This allows for specific and targeted amplification or analysis of a particular region of interest within a larger DNA molecule.

RNA Sequence Analysis is a branch of bioinformatics that involves the determination and analysis of the nucleotide sequence of Ribonucleic Acid (RNA) molecules. This process includes identifying and characterizing the individual RNA molecules, determining their functions, and studying their evolutionary relationships.

RNA Sequence Analysis typically involves the use of high-throughput sequencing technologies to generate large datasets of RNA sequences, which are then analyzed using computational methods. The analysis may include comparing the sequences to reference databases to identify known RNA molecules or discovering new ones, identifying patterns and features in the sequences, such as motifs or domains, and predicting the secondary and tertiary structures of the RNA molecules.

RNA Sequence Analysis has many applications in basic research, including understanding gene regulation, identifying novel non-coding RNAs, and studying evolutionary relationships between organisms. It also has practical applications in clinical settings, such as diagnosing and monitoring diseases, developing new therapies, and personalized medicine.

A conserved sequence in the context of molecular biology refers to a pattern of nucleotides (in DNA or RNA) or amino acids (in proteins) that has remained relatively unchanged over evolutionary time. These sequences are often functionally important and are highly conserved across different species, indicating strong selection pressure against changes in these regions.

In the case of protein-coding genes, the corresponding amino acid sequence is deduced from the DNA sequence through the genetic code. Conserved sequences in proteins may indicate structurally or functionally important regions, such as active sites or binding sites, that are critical for the protein's activity. Similarly, conserved non-coding sequences in DNA may represent regulatory elements that control gene expression.

Identifying conserved sequences can be useful for inferring evolutionary relationships between species and for predicting the function of unknown genes or proteins.

Ribonucleic acid (RNA) in plants refers to the long, single-stranded molecules that are essential for the translation of genetic information from deoxyribonucleic acid (DNA) into proteins. RNA is a nucleic acid, like DNA, and it is composed of a ribose sugar backbone with attached nitrogenous bases (adenine, uracil, guanine, and cytosine).

In plants, there are several types of RNA that play specific roles in the gene expression process:

1. Messenger RNA (mRNA): This type of RNA carries genetic information copied from DNA in the form of a sequence of three-base code units called codons. These codons specify the order of amino acids in a protein.
2. Transfer RNA (tRNA): tRNAs are small RNA molecules that serve as adaptors between the mRNA and the amino acids during protein synthesis. Each tRNA has a specific anticodon sequence that base-pairs with a complementary codon on the mRNA, and it carries a specific amino acid that corresponds to that codon.
3. Ribosomal RNA (rRNA): rRNAs are structural components of ribosomes, which are large macromolecular complexes where protein synthesis occurs. In plants, there are several types of rRNAs, including the 18S, 5.8S, and 25S/28S rRNAs, that form the core of the ribosome and help catalyze peptide bond formation during protein synthesis.
4. Small nuclear RNA (snRNA): These are small RNA molecules that play a role in RNA processing, such as splicing, where introns (non-coding sequences) are removed from pre-mRNA and exons (coding sequences) are joined together to form mature mRNAs.
5. MicroRNA (miRNA): These are small non-coding RNAs that regulate gene expression by binding to complementary sequences in target mRNAs, leading to their degradation or translation inhibition.

Overall, these different types of RNAs play crucial roles in various aspects of RNA metabolism, gene regulation, and protein synthesis in plants.

Magnesium is an essential mineral that plays a crucial role in various biological processes in the human body. It is the fourth most abundant cation in the body and is involved in over 300 enzymatic reactions, including protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Magnesium also contributes to the structural development of bones and teeth.

In medical terms, magnesium deficiency can lead to several health issues, such as muscle cramps, weakness, heart arrhythmias, and seizures. On the other hand, excessive magnesium levels can cause symptoms like diarrhea, nausea, and muscle weakness. Magnesium supplements or magnesium-rich foods are often recommended to maintain optimal magnesium levels in the body.

Some common dietary sources of magnesium include leafy green vegetables, nuts, seeds, legumes, whole grains, and dairy products. Magnesium is also available in various forms as a dietary supplement, including magnesium oxide, magnesium citrate, magnesium chloride, and magnesium glycinate.

A cell line is a culture of cells that are grown in a laboratory for use in research. These cells are usually taken from a single cell or group of cells, and they are able to divide and grow continuously in the lab. Cell lines can come from many different sources, including animals, plants, and humans. They are often used in scientific research to study cellular processes, disease mechanisms, and to test new drugs or treatments. Some common types of human cell lines include HeLa cells (which come from a cancer patient named Henrietta Lacks), HEK293 cells (which come from embryonic kidney cells), and HUVEC cells (which come from umbilical vein endothelial cells). It is important to note that cell lines are not the same as primary cells, which are cells that are taken directly from a living organism and have not been grown in the lab.

"Saccharomyces cerevisiae" is not typically considered a medical term, but it is a scientific name used in the field of microbiology. It refers to a species of yeast that is commonly used in various industrial processes, such as baking and brewing. It's also widely used in scientific research due to its genetic tractability and eukaryotic cellular organization.

However, it does have some relevance to medical fields like medicine and nutrition. For example, certain strains of S. cerevisiae are used as probiotics, which can provide health benefits when consumed. They may help support gut health, enhance the immune system, and even assist in the digestion of certain nutrients.

In summary, "Saccharomyces cerevisiae" is a species of yeast with various industrial and potential medical applications.

Endopeptidases are a type of enzyme that breaks down proteins by cleaving peptide bonds inside the polypeptide chain. They are also known as proteinases or endoproteinases. These enzymes work within the interior of the protein molecule, cutting it at specific points along its length, as opposed to exopeptidases, which remove individual amino acids from the ends of the protein chain.

Endopeptidases play a crucial role in various biological processes, such as digestion, blood coagulation, and programmed cell death (apoptosis). They are classified based on their catalytic mechanism and the structure of their active site. Some examples of endopeptidase families include serine proteases, cysteine proteases, aspartic proteases, and metalloproteases.

It is important to note that while endopeptidases are essential for normal physiological functions, they can also contribute to disease processes when their activity is unregulated or misdirected. For instance, excessive endopeptidase activity has been implicated in the pathogenesis of neurodegenerative disorders, cancer, and inflammatory conditions.

I'd be happy to help! However, I believe there might be a slight confusion in your question. RNA stands for Ribonucleic Acid, which is a type of nucleic acid involved in various biological roles in the coding, decoding, regulation, and expression of genes. On the other hand, protozoan refers to a unicellular organism from the kingdom Protista, which includes a wide variety of simple eukaryotic organisms such as amoebas, paramecia, and plasmodium (the malaria-causing parasite).

There isn't a specific medical definition for "RNA, protozoan" since RNA is a molecule present in all living cells, including human cells, and protozoans are a group of organisms. However, I can tell you that RNA plays crucial roles in protozoan biology, such as acting as a messenger between DNA and ribosomes during protein synthesis or regulating gene expression.

If you have any further questions or need more specific information about RNA in protozoans, please let me know!

Deoxyribonucleic acid (DNA) is the genetic material present in the cells of organisms where it is responsible for the storage and transmission of hereditary information. DNA is a long molecule that consists of two strands coiled together to form a double helix. Each strand is made up of a series of four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - that are linked together by phosphate and sugar groups. The sequence of these bases along the length of the molecule encodes genetic information, with A always pairing with T and C always pairing with G. This base-pairing allows for the replication and transcription of DNA, which are essential processes in the functioning and reproduction of all living organisms.

MicroRNAs (miRNAs) are a class of small non-coding RNAs, typically consisting of around 20-24 nucleotides, that play crucial roles in post-transcriptional regulation of gene expression. They primarily bind to the 3' untranslated region (3' UTR) of target messenger RNAs (mRNAs), leading to mRNA degradation or translational repression. MicroRNAs are involved in various biological processes, including development, differentiation, proliferation, and apoptosis, and have been implicated in numerous diseases, such as cancers and neurological disorders. They can be found in various organisms, from plants to animals, and are often conserved across species. MicroRNAs are usually transcribed from DNA sequences located in introns or exons of protein-coding genes or in intergenic regions. After transcription, they undergo a series of processing steps, including cleavage by ribonucleases Drosha and Dicer, to generate mature miRNA molecules capable of binding to their target mRNAs.

Post-translational protein processing refers to the modifications and changes that proteins undergo after their synthesis on ribosomes, which are complex molecular machines responsible for protein synthesis. These modifications occur through various biochemical processes and play a crucial role in determining the final structure, function, and stability of the protein.

The process begins with the translation of messenger RNA (mRNA) into a linear polypeptide chain, which is then subjected to several post-translational modifications. These modifications can include:

1. Proteolytic cleavage: The removal of specific segments or domains from the polypeptide chain by proteases, resulting in the formation of mature, functional protein subunits.
2. Chemical modifications: Addition or modification of chemical groups to the side chains of amino acids, such as phosphorylation (addition of a phosphate group), glycosylation (addition of sugar moieties), methylation (addition of a methyl group), acetylation (addition of an acetyl group), and ubiquitination (addition of a ubiquitin protein).
3. Disulfide bond formation: The oxidation of specific cysteine residues within the polypeptide chain, leading to the formation of disulfide bonds between them. This process helps stabilize the three-dimensional structure of proteins, particularly in extracellular environments.
4. Folding and assembly: The acquisition of a specific three-dimensional conformation by the polypeptide chain, which is essential for its function. Chaperone proteins assist in this process to ensure proper folding and prevent aggregation.
5. Protein targeting: The directed transport of proteins to their appropriate cellular locations, such as the nucleus, mitochondria, endoplasmic reticulum, or plasma membrane. This is often facilitated by specific signal sequences within the protein that are recognized and bound by transport machinery.

Collectively, these post-translational modifications contribute to the functional diversity of proteins in living organisms, allowing them to perform a wide range of cellular processes, including signaling, catalysis, regulation, and structural support.

RNA-dependent RNA polymerase, also known as RNA replicase, is an enzyme that catalyzes the production of RNA from an RNA template. It plays a crucial role in the replication of certain viruses, such as positive-strand RNA viruses and retroviruses, which use RNA as their genetic material. The enzyme uses the existing RNA strand as a template to create a new complementary RNA strand, effectively replicating the viral genome. This process is essential for the propagation of these viruses within host cells and is a target for antiviral therapies.

RNA (Ribonucleic acid) is a single-stranded molecule similar in structure to DNA, involved in the process of protein synthesis in the cell. It acts as a messenger carrying genetic information from DNA to the ribosomes, where proteins are produced.

A neoplasm, on the other hand, is an abnormal growth of cells, which can be benign or malignant. Benign neoplasms are not cancerous and do not invade nearby tissues or spread to other parts of the body. Malignant neoplasms, however, are cancerous and have the potential to invade surrounding tissues and spread to distant sites in the body through a process called metastasis.

Therefore, an 'RNA neoplasm' is not a recognized medical term as RNA is not a type of growth or tumor. However, there are certain types of cancer-causing viruses known as oncoviruses that contain RNA as their genetic material and can cause neoplasms. For example, human T-cell leukemia virus (HTLV-1) and hepatitis C virus (HCV) are RNA viruses that can cause certain types of cancer in humans.

X-ray crystallography is a technique used in structural biology to determine the three-dimensional arrangement of atoms in a crystal lattice. In this method, a beam of X-rays is directed at a crystal and diffracts, or spreads out, into a pattern of spots called reflections. The intensity and angle of each reflection are measured and used to create an electron density map, which reveals the position and type of atoms in the crystal. This information can be used to determine the molecular structure of a compound, including its shape, size, and chemical bonds. X-ray crystallography is a powerful tool for understanding the structure and function of biological macromolecules such as proteins and nucleic acids.

Saccharomyces cerevisiae proteins are the proteins that are produced by the budding yeast, Saccharomyces cerevisiae. This organism is a single-celled eukaryote that has been widely used as a model organism in scientific research for many years due to its relatively simple genetic makeup and its similarity to higher eukaryotic cells.

The genome of Saccharomyces cerevisiae has been fully sequenced, and it is estimated to contain approximately 6,000 genes that encode proteins. These proteins play a wide variety of roles in the cell, including catalyzing metabolic reactions, regulating gene expression, maintaining the structure of the cell, and responding to environmental stimuli.

Many Saccharomyces cerevisiae proteins have human homologs and are involved in similar biological processes, making this organism a valuable tool for studying human disease. For example, many of the proteins involved in DNA replication, repair, and recombination in yeast have human counterparts that are associated with cancer and other diseases. By studying these proteins in yeast, researchers can gain insights into their function and regulation in humans, which may lead to new treatments for disease.

DEAD-box RNA helicases are a family of proteins that are involved in unwinding RNA secondary structures and displacing proteins bound to RNA molecules. They get their name from the conserved amino acid sequence motif "DEAD" (Asp-Glu-Ala-Asp) found within their catalytic core, which is responsible for ATP-dependent helicase activity. These enzymes play crucial roles in various aspects of RNA metabolism, including pre-mRNA splicing, ribosome biogenesis, translation initiation, and RNA decay. DEAD-box helicases are also implicated in a number of human diseases, such as cancer and neurological disorders.

A guide RNA (gRNA) is not a type of RNA itself, but rather a term used to describe various types of RNAs that guide other molecules to specific target sites in the genome or transcriptome. The most well-known example of a guide RNA is the CRISPR RNA (crRNA) used in the CRISPR-Cas system for targeted gene editing.

The crRNA contains a sequence complementary to the target DNA or RNA, and it guides the Cas endonuclease to the correct location in the genome where cleavage and modification can occur. Other types of guide RNAs include small interfering RNAs (siRNAs) and microRNAs (miRNAs), which guide the RNA-induced silencing complex (RISC) to specific mRNA targets for degradation or translational repression.

Overall, guide RNAs play crucial roles in various cellular processes, including gene regulation, genome editing, and defense against foreign genetic elements.

RNA Polymerase III is a type of enzyme that carries out the transcription of DNA into RNA, specifically functioning in the synthesis of small, stable RNAs. These RNAs include 5S rRNA, transfer RNAs (tRNAs), and other small nuclear RNAs (snRNAs). The enzyme recognizes specific promoter sequences in DNA and catalyzes the formation of phosphodiester bonds between ribonucleotides to create a complementary RNA strand. RNA Polymerase III is essential for protein synthesis and cell survival, and its activity is tightly regulated within the cell.

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

A peptide fragment is a short chain of amino acids that is derived from a larger peptide or protein through various biological or chemical processes. These fragments can result from the natural breakdown of proteins in the body during regular physiological processes, such as digestion, or they can be produced experimentally in a laboratory setting for research or therapeutic purposes.

Peptide fragments are often used in research to map the structure and function of larger peptides and proteins, as well as to study their interactions with other molecules. In some cases, peptide fragments may also have biological activity of their own and can be developed into drugs or diagnostic tools. For example, certain peptide fragments derived from hormones or neurotransmitters may bind to receptors in the body and mimic or block the effects of the full-length molecule.

mRNA cleavage and polyadenylation factors are a group of proteins that play a crucial role in the post-transcriptional modification of messenger RNA (mRNA). This process involves two main steps: mRNA cleavage and polyadenylation.

1. Cleavage: During this step, the mRNA molecule is cut at a specific site, resulting in the formation of two separate fragments. The fragment that will become the mature mRNA is called the 3' untranslated region (3' UTR).

2. Polyadenylation: Following cleavage, a string of adenine nucleotides (poly(A) tail) is added to the 3' end of the newly formed 3' UTR. This poly(A) tail plays an essential role in mRNA stability, transport from the nucleus to the cytoplasm, and translation initiation.

mRNA cleavage and polyadenylation factors include various proteins that orchestrate these events, such as:

* Cleavage and polyadenylation specificity factor (CPSF) complex: This complex recognizes and binds to the polyadenylation signal sequence in the pre-mRNA. It contains several subunits, including CPSF1, CPSF2, CPSF3, CPSF4, and CPSF7.
* Cleavage stimulation factor (CstF) complex: This complex recognizes and binds to the GU-rich region downstream of the polyadenylation signal sequence. It contains several subunits, including CstF50, CstF64, CstF77, and CstF80.
* Cleavage factors I (CFIm) and II (CFIIm): These complexes help position the CPSF complex at the correct site for cleavage and polyadenylation. CFIm contains the subunits CFIm25, CFIm59, and CFIm68, while CFIIm consists of the subunits CLIP1 and PAP73.
* Poly(A) polymerase (PAP): This enzyme adds the string of adenine residues to the 3' end of the pre-mRNA after cleavage.

Together, these factors work together to ensure accurate and efficient cleavage and polyadenylation of pre-mRNAs during gene expression.

18S rRNA (ribosomal RNA) is the smaller subunit of the eukaryotic ribosome, which is the cellular organelle responsible for protein synthesis. The "18S" refers to the sedimentation coefficient of this rRNA molecule, which is a measure of its rate of sedimentation in a centrifuge and is expressed in Svedberg units (S).

The 18S rRNA is a component of the 40S subunit of the ribosome, and it plays a crucial role in the decoding of messenger RNA (mRNA) during protein synthesis. Specifically, the 18S rRNA helps to form the structure of the ribosome and contains several conserved regions that are involved in binding to mRNA and guiding the movement of transfer RNAs (tRNAs) during translation.

The 18S rRNA is also a commonly used molecular marker for evolutionary studies, as its sequence is highly conserved across different species and can be used to infer phylogenetic relationships between organisms. Additionally, the analysis of 18S rRNA gene sequences has been widely used in various fields such as ecology, environmental science, and medicine to study biodiversity, biogeography, and infectious diseases.

RNA Polymerase I is a type of enzyme that carries out the transcription of ribosomal RNA (rRNA) genes in eukaryotic cells. These enzymes are responsible for synthesizing the rRNA molecules, which are crucial components of ribosomes, the cellular structures where protein synthesis occurs. RNA Polymerase I is found in the nucleolus, a specialized region within the nucleus of eukaryotic cells, and it primarily transcribes the 5S, 18S, and 28S rRNA genes. The enzyme binds to the promoter regions of these genes and synthesizes the rRNA molecules by adding ribonucleotides in a template-directed manner, using DNA as a template. This process is essential for maintaining normal cellular function and for the production of proteins required for growth, development, and homeostasis.

'RNA, Nuclear' refers to Ribonucleic Acid that is located within the nucleus of a eukaryotic cell. It plays a crucial role in the process of gene expression, specifically in the transcription of DNA into messenger RNA (mRNA). During this process, a segment of DNA is copied into a complementary RNA strand, known as a primary transcript. This primary transcript then undergoes various processing steps within the nucleus, such as splicing and capping, to produce mature, functional mRNA. Nuclear RNA also includes other non-coding RNAs, such as ribosomal RNA (rRNA), transfer RNA (tRNA), and small nuclear RNA (snRNA), which are involved in various cellular processes including protein synthesis and regulation of gene expression.

Caspases are a family of protease enzymes that play essential roles in programmed cell death, also known as apoptosis. These enzymes are produced as inactive precursors and are activated when cells receive signals to undergo apoptosis. Once activated, caspases cleave specific protein substrates, leading to the characteristic morphological changes and DNA fragmentation associated with apoptotic cell death. Caspases also play roles in other cellular processes, including inflammation and differentiation. There are two types of caspases: initiator caspases (caspase-2, -8, -9, and -10) and effector caspases (caspase-3, -6, and -7). Initiator caspases are activated in response to various apoptotic signals and then activate the effector caspases, which carry out the proteolytic cleavage of cellular proteins. Dysregulation of caspase activity has been implicated in a variety of diseases, including neurodegenerative disorders, ischemic injury, and cancer.

Molecular weight, also known as molecular mass, is the mass of a molecule. It is expressed in units of atomic mass units (amu) or daltons (Da). Molecular weight is calculated by adding up the atomic weights of each atom in a molecule. It is a useful property in chemistry and biology, as it can be used to determine the concentration of a substance in a solution, or to calculate the amount of a substance that will react with another in a chemical reaction.

Electrophoresis, polyacrylamide gel (EPG) is a laboratory technique used to separate and analyze complex mixtures of proteins or nucleic acids (DNA or RNA) based on their size and electrical charge. This technique utilizes a matrix made of cross-linked polyacrylamide, a type of gel, which provides a stable and uniform environment for the separation of molecules.

In this process:

1. The polyacrylamide gel is prepared by mixing acrylamide monomers with a cross-linking agent (bis-acrylamide) and a catalyst (ammonium persulfate) in the presence of a buffer solution.
2. The gel is then poured into a mold and allowed to polymerize, forming a solid matrix with uniform pore sizes that depend on the concentration of acrylamide used. Higher concentrations result in smaller pores, providing better resolution for separating smaller molecules.
3. Once the gel has set, it is placed in an electrophoresis apparatus containing a buffer solution. Samples containing the mixture of proteins or nucleic acids are loaded into wells on the top of the gel.
4. An electric field is applied across the gel, causing the negatively charged molecules to migrate towards the positive electrode (anode) while positively charged molecules move toward the negative electrode (cathode). The rate of migration depends on the size, charge, and shape of the molecules.
5. Smaller molecules move faster through the gel matrix and will migrate farther from the origin compared to larger molecules, resulting in separation based on size. Proteins and nucleic acids can be selectively stained after electrophoresis to visualize the separated bands.

EPG is widely used in various research fields, including molecular biology, genetics, proteomics, and forensic science, for applications such as protein characterization, DNA fragment analysis, cloning, mutation detection, and quality control of nucleic acid or protein samples.

Furin is not a medical condition or disease, but rather it is a type of enzyme that belongs to the group of proteases. It's also known as paired basic amino acid cleaving enzyme (PACE) or convertase 6.

Furin plays an essential role in processing and activating various proteins in the body, particularly those involved in cell signaling, growth regulation, and viral infectivity. Furin works by cutting or cleaving specific amino acid sequences in proteins, allowing them to become active and perform their functions.

In a medical context, furin is often discussed in relation to its role in activating certain viruses, such as HIV, influenza, and coronaviruses (including SARS-CoV-2). Inhibiting furin activity has been explored as a potential therapeutic strategy for treating these viral infections.

Protein precursors, also known as proproteins or prohormones, are inactive forms of proteins that undergo post-translational modification to become active. These modifications typically include cleavage of the precursor protein by specific enzymes, resulting in the release of the active protein. This process allows for the regulation and control of protein activity within the body. Protein precursors can be found in various biological processes, including the endocrine system where they serve as inactive hormones that can be converted into their active forms when needed.

Serine endopeptidases are a type of enzymes that cleave peptide bonds within proteins (endopeptidases) and utilize serine as the nucleophilic amino acid in their active site for catalysis. These enzymes play crucial roles in various biological processes, including digestion, blood coagulation, and programmed cell death (apoptosis). Examples of serine endopeptidases include trypsin, chymotrypsin, thrombin, and elastase.

23S Ribosomal RNA (rRNA) is a type of rRNA that is a component of the large ribosomal subunit in both prokaryotic and eukaryotic cells. In prokaryotes, the large ribosomal subunit contains 50S, which consists of 23S rRNA, 5S rRNA, and around 33 proteins. The 23S rRNA plays a crucial role in the decoding of mRNA during protein synthesis and also participates in the formation of the peptidyl transferase center, where peptide bonds are formed between amino acids.

The 23S rRNA is a long RNA molecule that contains both coding and non-coding regions. It has a complex secondary structure, which includes several domains and subdomains, as well as numerous stem-loop structures. These structures are important for the proper functioning of the ribosome during protein synthesis.

In addition to its role in protein synthesis, 23S rRNA has been used as a target for antibiotics that inhibit bacterial growth. For example, certain antibiotics bind to specific regions of the 23S rRNA and interfere with the function of the ribosome, thereby preventing bacterial protein synthesis and growth. However, because eukaryotic cells do not have a 23S rRNA equivalent, these antibiotics are generally not toxic to human cells.

Virus replication is the process by which a virus produces copies or reproduces itself inside a host cell. This involves several steps:

1. Attachment: The virus attaches to a specific receptor on the surface of the host cell.
2. Penetration: The viral genetic material enters the host cell, either by invagination of the cell membrane or endocytosis.
3. Uncoating: The viral genetic material is released from its protective coat (capsid) inside the host cell.
4. Replication: The viral genetic material uses the host cell's machinery to produce new viral components, such as proteins and nucleic acids.
5. Assembly: The newly synthesized viral components are assembled into new virus particles.
6. Release: The newly formed viruses are released from the host cell, often through lysis (breaking) of the cell membrane or by budding off the cell membrane.

The specific mechanisms and details of virus replication can vary depending on the type of virus. Some viruses, such as DNA viruses, use the host cell's DNA polymerase to replicate their genetic material, while others, such as RNA viruses, use their own RNA-dependent RNA polymerase or reverse transcriptase enzymes. Understanding the process of virus replication is important for developing antiviral therapies and vaccines.

Apoptosis is a programmed and controlled cell death process that occurs in multicellular organisms. It is a natural process that helps maintain tissue homeostasis by eliminating damaged, infected, or unwanted cells. During apoptosis, the cell undergoes a series of morphological changes, including cell shrinkage, chromatin condensation, and fragmentation into membrane-bound vesicles called apoptotic bodies. These bodies are then recognized and engulfed by neighboring cells or phagocytic cells, preventing an inflammatory response. Apoptosis is regulated by a complex network of intracellular signaling pathways that involve proteins such as caspases, Bcl-2 family members, and inhibitors of apoptosis (IAPs).

Site-directed mutagenesis is a molecular biology technique used to introduce specific and targeted changes to a specific DNA sequence. This process involves creating a new variant of a gene or a specific region of interest within a DNA molecule by introducing a planned, deliberate change, or mutation, at a predetermined site within the DNA sequence.

The methodology typically involves the use of molecular tools such as PCR (polymerase chain reaction), restriction enzymes, and/or ligases to introduce the desired mutation(s) into a plasmid or other vector containing the target DNA sequence. The resulting modified DNA molecule can then be used to transform host cells, allowing for the production of large quantities of the mutated gene or protein for further study.

Site-directed mutagenesis is a valuable tool in basic research, drug discovery, and biotechnology applications where specific changes to a DNA sequence are required to understand gene function, investigate protein structure/function relationships, or engineer novel biological properties into existing genes or proteins.

"RNA 3' end processing" refers to the post-transcriptional modifications that occur at the 3' end of RNA transcripts. While "RNA 3' end processing" is not a specific medical term, it is a fundamental biological process that has implications in various areas of medicine, such as gene regulation and disease pathogenesis.

During RNA 3' end processing, several enzymatic activities take place to generate a mature and functional RNA molecule. These modifications typically include the removal of unnecessary sequences, the addition of a poly(A) tail, and sometimes the incorporation of a specific nucleotide called a "cap."

1. Removal of unnecessary sequences: In many cases, the initial RNA transcript contains non-coding regions (introns) that need to be removed to generate a mature RNA molecule. This process is known as splicing, and it results in the formation of an mRNA (messenger RNA) or other types of functional RNAs, such as rRNA (ribosomal RNA), tRNA (transfer RNA), or snRNA (small nuclear RNA).
2. Addition of a poly(A) tail: After splicing, the 3' end of the RNA molecule is further processed by adding a string of adenine nucleotides, known as a poly(A) tail. This modification is catalyzed by an enzyme called poly(A) polymerase and plays a crucial role in stabilizing the RNA molecule, promoting its export from the nucleus to the cytoplasm, and facilitating translation.
3. Incorporation of a cap: At the 5' end of the RNA molecule, a special structure called a "cap" is added. This cap consists of a modified guanine nucleotide that is linked to the first nucleotide of the RNA via a triphosphate bridge. The cap helps protect the RNA from degradation and plays a role in translation initiation by recruiting ribosomes and other translation factors.

Dysregulation of RNA 3' end processing has been implicated in various diseases, including cancer, neurological disorders, and viral infections. Understanding the molecular mechanisms underlying these processes can provide valuable insights into disease pathogenesis and potential therapeutic targets.

Cysteine endopeptidases are a type of enzymes that cleave peptide bonds within proteins. They are also known as cysteine proteases or cysteine proteinases. These enzymes contain a catalytic triad consisting of three amino acids: cysteine, histidine, and aspartate. The thiol group (-SH) of the cysteine residue acts as a nucleophile and attacks the carbonyl carbon of the peptide bond, leading to its cleavage.

Cysteine endopeptidases play important roles in various biological processes, including protein degradation, cell signaling, and inflammation. They are involved in many physiological and pathological conditions, such as apoptosis, immune response, and cancer. Some examples of cysteine endopeptidases include cathepsins, caspases, and calpains.

It is important to note that these enzymes require a reducing environment to maintain the reduced state of their active site cysteine residue. Therefore, they are sensitive to oxidizing agents and inhibitors that target the thiol group. Understanding the structure and function of cysteine endopeptidases is crucial for developing therapeutic strategies that target these enzymes in various diseases.

Caspase-3 is a type of protease enzyme that plays a central role in the execution-phase of cell apoptosis, or programmed cell death. It's also known as CPP32 (CPP for ced-3 protease precursor) or apopain. Caspase-3 is produced as an inactive protein that is activated when cleaved by other caspases during the early stages of apoptosis. Once activated, it cleaves a variety of cellular proteins, including structural proteins, enzymes, and signal transduction proteins, leading to the characteristic morphological and biochemical changes associated with apoptotic cell death. Caspase-3 is often referred to as the "death protease" because of its crucial role in executing the cell death program.

A satellite RNA is a type of non-coding RNA that does not encode proteins but instead plays a role in the regulation of gene expression. It is so named because it can exist as a separate, smaller molecule that "satellites" around a larger RNA molecule called the helper RNA. Satellite RNAs are often associated with viruses and can affect their replication and packaging. They can also be found in some eukaryotic cells, where they may play a role in regulating the expression of certain genes or in the development of diseases such as cancer.

RNA transport refers to the process by which messenger RNA (mRNA) molecules are transferred from the nucleus to the cytoplasm in eukaryotic cells. After being transcribed in the nucleus, mRNA molecules must be transported to the cytoplasm where they can be translated into proteins on ribosomes. This process is essential for gene expression and involves a complex network of proteins and RNA-binding factors that facilitate the recognition, packaging, and transport of mRNA through the nuclear pore complex.

The transport of mRNA is a highly regulated process that ensures the proper localization and translation of specific mRNAs in response to various cellular signals. Abnormalities in RNA transport have been implicated in several neurological disorders, including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).

The cell nucleus is a membrane-bound organelle found in the eukaryotic cells (cells with a true nucleus). It contains most of the cell's genetic material, organized as DNA molecules in complex with proteins, RNA molecules, and histones to form chromosomes.

The primary function of the cell nucleus is to regulate and control the activities of the cell, including growth, metabolism, protein synthesis, and reproduction. It also plays a crucial role in the process of mitosis (cell division) by separating and protecting the genetic material during this process. The nuclear membrane, or nuclear envelope, surrounding the nucleus is composed of two lipid bilayers with numerous pores that allow for the selective transport of molecules between the nucleoplasm (nucleus interior) and the cytoplasm (cell exterior).

The cell nucleus is a vital structure in eukaryotic cells, and its dysfunction can lead to various diseases, including cancer and genetic disorders.

Transfection is a term used in molecular biology that refers to the process of deliberately introducing foreign genetic material (DNA, RNA or artificial gene constructs) into cells. This is typically done using chemical or physical methods, such as lipofection or electroporation. Transfection is widely used in research and medical settings for various purposes, including studying gene function, producing proteins, developing gene therapies, and creating genetically modified organisms. It's important to note that transfection is different from transduction, which is the process of introducing genetic material into cells using viruses as vectors.

Peptide hydrolases, also known as proteases or peptidases, are a group of enzymes that catalyze the hydrolysis of peptide bonds in proteins and peptides. They play a crucial role in various biological processes such as protein degradation, digestion, cell signaling, and regulation of various physiological functions. Based on their catalytic mechanism and the specificity for the peptide bond, they are classified into several types, including serine proteases, cysteine proteases, aspartic proteases, and metalloproteases. These enzymes have important clinical applications in the diagnosis and treatment of various diseases, such as cancer, viral infections, and inflammatory disorders.

"Spliced leader RNA (SL-RNA)" is a type of RNA molecule that is present in some single-celled eukaryotic organisms, such as trypanosomes and nematodes. In these organisms, spliced leader RNAs play a critical role in the process of gene expression by providing a "leader" sequence that is added to the beginning of messenger RNA (mRNA) molecules during the process of RNA splicing.

SL-RNAs are typically composed of two regions: a conserved 5' " leader" sequence, which is added to the beginning of mRNAs, and a variable 3' " trailer" sequence, which contains the sequences required for recognition and cleavage by the splicing machinery. During RNA splicing, the spliced leader RNA is joined to the target mRNA through a process called trans-splicing, in which the leader sequence of the SL-RNA is ligated to the 5' end of the target mRNA, replacing the original 5' exon.

The addition of the spliced leader sequence to mRNAs can have several important consequences for gene expression. For example, it can help ensure that all mRNAs produced from a given gene contain the same 5' end, even if the gene is transcribed from multiple promoters or undergoes alternative splicing. Additionally, the presence of the conserved leader sequence can serve as a recognition site for RNA-binding proteins, which can regulate mRNA stability, localization, and translation.

Overall, spliced leader RNAs are an important component of the gene expression machinery in many eukaryotic organisms, and their study has provided valuable insights into the mechanisms of RNA processing and regulation.

Archaeal RNA refers to the Ribonucleic acid (RNA) molecules that are present in archaea, which are a domain of single-celled microorganisms. RNA is a nucleic acid that plays a crucial role in various biological processes, such as protein synthesis, gene expression, and regulation of cellular activities.

Archaeal RNAs can be categorized into different types based on their functions, including:

1. Messenger RNA (mRNA): It carries genetic information from DNA to the ribosome, where it is translated into proteins.
2. Transfer RNA (tRNA): It helps in translating the genetic code present in mRNA into specific amino acids during protein synthesis.
3. Ribosomal RNA (rRNA): It is a structural and functional component of ribosomes, where protein synthesis occurs.
4. Non-coding RNA: These are RNAs that do not code for proteins but have regulatory functions in gene expression and other cellular processes.

Archaeal RNAs share similarities with both bacterial and eukaryotic RNAs, but they also possess unique features that distinguish them from the other two domains of life. For example, archaeal rRNAs contain unique sequence motifs and secondary structures that are not found in bacteria or eukaryotes. These differences suggest that archaeal RNAs have evolved to adapt to the extreme environments where many archaea live.

Overall, understanding the structure, function, and evolution of archaeal RNA is essential for gaining insights into the biology of these unique microorganisms and their roles in various cellular processes.

Oligonucleotides are short sequences of nucleotides, the building blocks of DNA and RNA. They typically contain fewer than 100 nucleotides, and can be synthesized chemically to have specific sequences. Oligonucleotides are used in a variety of applications in molecular biology, including as probes for detecting specific DNA or RNA sequences, as inhibitors of gene expression, and as components of diagnostic tests and therapies. They can also be used in the study of protein-nucleic acid interactions and in the development of new drugs.

Viral DNA refers to the genetic material present in viruses that consist of DNA as their core component. Deoxyribonucleic acid (DNA) is one of the two types of nucleic acids that are responsible for storing and transmitting genetic information in living organisms. Viruses are infectious agents much smaller than bacteria that can only replicate inside the cells of other organisms, called hosts.

Viral DNA can be double-stranded (dsDNA) or single-stranded (ssDNA), depending on the type of virus. Double-stranded DNA viruses have a genome made up of two complementary strands of DNA, while single-stranded DNA viruses contain only one strand of DNA.

Examples of dsDNA viruses include Adenoviruses, Herpesviruses, and Poxviruses, while ssDNA viruses include Parvoviruses and Circoviruses. Viral DNA plays a crucial role in the replication cycle of the virus, encoding for various proteins necessary for its multiplication and survival within the host cell.

Ribosomal RNA (rRNA) is a type of RNA that combines with proteins to form ribosomes, which are complex structures inside cells where protein synthesis occurs. The "16S" refers to the sedimentation coefficient of the rRNA molecule, which is a measure of its size and shape. In particular, 16S rRNA is a component of the smaller subunit of the prokaryotic ribosome (found in bacteria and archaea), and is often used as a molecular marker for identifying and classifying these organisms due to its relative stability and conservation among species. The sequence of 16S rRNA can be compared across different species to determine their evolutionary relationships and taxonomic positions.

Proteolysis is the biological process of breaking down proteins into smaller polypeptides or individual amino acids by the action of enzymes called proteases. This process is essential for various physiological functions, including digestion, protein catabolism, cell signaling, and regulation of numerous biological activities. Dysregulation of proteolysis can contribute to several pathological conditions, such as cancer, neurodegenerative diseases, and inflammatory disorders.

The Cholesterol Side-Chain Cleavage Enzyme, also known as Steroidogenic Acute Regulatory (StAR) protein or P450scc, is a complex enzymatic system that plays a crucial role in the production of steroid hormones. It is located in the inner mitochondrial membrane of steroid-producing cells, such as those found in the adrenal glands, gonads, and placenta.

The Cholesterol Side-Chain Cleavage Enzyme is responsible for converting cholesterol into pregnenolone, which is the first step in the biosynthesis of all steroid hormones, including cortisol, aldosterone, sex hormones, and vitamin D. This enzymatic complex consists of two components: a flavoprotein called NADPH-cytochrome P450 oxidoreductase, which provides electrons for the reaction, and a cytochrome P450 protein called CYP11A1, which catalyzes the actual cleavage of the cholesterol side chain.

Defects in the Cholesterol Side-Chain Cleavage Enzyme can lead to various genetic disorders, such as congenital lipoid adrenal hyperplasia (CLAH), a rare autosomal recessive disorder characterized by impaired steroidogenesis and accumulation of cholesteryl esters in the adrenal glands and gonads.

Subtilisins are a group of serine proteases that are produced by certain bacteria, including Bacillus subtilis. They are named after the bacterium and the Latin word "subtilis," which means delicate or finely made. Subtilisins are alkaline proteases, meaning they work best in slightly basic conditions.

Subtilisins have a broad specificity for cleaving peptide bonds and can hydrolyze a wide range of protein substrates. They are widely used in industry for various applications such as detergents, food processing, leather treatment, and biotechnology due to their ability to function at high temperatures and in the presence of denaturing agents.

In medicine, subtilisins have been studied for their potential use in therapeutic applications, including as anti-inflammatory agents and in wound healing. However, more research is needed to fully understand their mechanisms of action and potential benefits.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Ribonucleoproteins (RNPs) are complexes composed of ribonucleic acid (RNA) and proteins. They play crucial roles in various cellular processes, including gene expression, RNA processing, transport, stability, and degradation. Different types of RNPs exist, such as ribosomes, spliceosomes, and signal recognition particles, each having specific functions in the cell.

Ribosomes are large RNP complexes responsible for protein synthesis, where messenger RNA (mRNA) is translated into proteins. They consist of two subunits: a smaller subunit containing ribosomal RNA (rRNA) and proteins that recognize the start codon on mRNA, and a larger subunit with rRNA and proteins that facilitate peptide bond formation during translation.

Spliceosomes are dynamic RNP complexes involved in pre-messenger RNA (pre-mRNA) splicing, where introns (non-coding sequences) are removed, and exons (coding sequences) are joined together to form mature mRNA. Spliceosomes consist of five small nuclear ribonucleoproteins (snRNPs), each containing a specific small nuclear RNA (snRNA) and several proteins, as well as numerous additional proteins.

Other RNP complexes include signal recognition particles (SRPs), which are responsible for targeting secretory and membrane proteins to the endoplasmic reticulum during translation, and telomerase, an enzyme that maintains the length of telomeres (the protective ends of chromosomes) by adding repetitive DNA sequences using its built-in RNA component.

In summary, ribonucleoproteins are essential complexes in the cell that participate in various aspects of RNA metabolism and protein synthesis.

Amyloid precursor protein (APP) secretases are enzymes that are responsible for cleaving the amyloid precursor protein into various smaller proteins. There are two types of APP secretases: α-secretase and β-secretase.

α-Secretase is a member of the ADAM (a disintegrin and metalloproteinase) family, specifically ADAM10 and ADAM17. When APP is cleaved by α-secretase, it produces a large ectodomain called sAPPα and a membrane-bound C-terminal fragment called C83. This pathway is known as the non-amyloidogenic pathway because it prevents the formation of amyloid-β (Aβ) peptides, which are associated with Alzheimer's disease.

β-Secretase, also known as β-site APP cleaving enzyme 1 (BACE1), is a type II transmembrane aspartic protease. When APP is cleaved by β-secretase, it produces a large ectodomain called sAPPβ and a membrane-bound C-terminal fragment called C99. Subsequently, C99 is further cleaved by γ-secretase to generate Aβ peptides, including the highly neurotoxic Aβ42. This pathway is known as the amyloidogenic pathway because it leads to the formation of Aβ peptides and the development of Alzheimer's disease.

Therefore, APP secretases play a crucial role in the regulation of APP processing and have been the focus of extensive research in the context of Alzheimer's disease and other neurodegenerative disorders.

DNA restriction enzymes, also known as restriction endonucleases, are a type of enzyme that cut double-stranded DNA at specific recognition sites. These enzymes are produced by bacteria and archaea as a defense mechanism against foreign DNA, such as that found in bacteriophages (viruses that infect bacteria).

Restriction enzymes recognize specific sequences of nucleotides (the building blocks of DNA) and cleave the phosphodiester bonds between them. The recognition sites for these enzymes are usually palindromic, meaning that the sequence reads the same in both directions when facing the opposite strands of DNA.

Restriction enzymes are widely used in molecular biology research for various applications such as genetic engineering, genome mapping, and DNA fingerprinting. They allow scientists to cut DNA at specific sites, creating precise fragments that can be manipulated and analyzed. The use of restriction enzymes has been instrumental in the development of recombinant DNA technology and the Human Genome Project.

A viral genome is the genetic material (DNA or RNA) that is present in a virus. It contains all the genetic information that a virus needs to replicate itself and infect its host. The size and complexity of viral genomes can vary greatly, ranging from a few thousand bases to hundreds of thousands of bases. Some viruses have linear genomes, while others have circular genomes. The genome of a virus also contains the information necessary for the virus to hijack the host cell's machinery and use it to produce new copies of the virus. Understanding the genetic makeup of viruses is important for developing vaccines and antiviral treatments.

A Structure-Activity Relationship (SAR) in the context of medicinal chemistry and pharmacology refers to the relationship between the chemical structure of a drug or molecule and its biological activity or effect on a target protein, cell, or organism. SAR studies aim to identify patterns and correlations between structural features of a compound and its ability to interact with a specific biological target, leading to a desired therapeutic response or undesired side effects.

By analyzing the SAR, researchers can optimize the chemical structure of lead compounds to enhance their potency, selectivity, safety, and pharmacokinetic properties, ultimately guiding the design and development of novel drugs with improved efficacy and reduced toxicity.

Recombinant fusion proteins are artificially created biomolecules that combine the functional domains or properties of two or more different proteins into a single protein entity. They are generated through recombinant DNA technology, where the genes encoding the desired protein domains are linked together and expressed as a single, chimeric gene in a host organism, such as bacteria, yeast, or mammalian cells.

The resulting fusion protein retains the functional properties of its individual constituent proteins, allowing for novel applications in research, diagnostics, and therapeutics. For instance, recombinant fusion proteins can be designed to enhance protein stability, solubility, or immunogenicity, making them valuable tools for studying protein-protein interactions, developing targeted therapies, or generating vaccines against infectious diseases or cancer.

Examples of recombinant fusion proteins include:

1. Etaglunatide (ABT-523): A soluble Fc fusion protein that combines the heavy chain fragment crystallizable region (Fc) of an immunoglobulin with the extracellular domain of the human interleukin-6 receptor (IL-6R). This fusion protein functions as a decoy receptor, neutralizing IL-6 and its downstream signaling pathways in rheumatoid arthritis.
2. Etanercept (Enbrel): A soluble TNF receptor p75 Fc fusion protein that binds to tumor necrosis factor-alpha (TNF-α) and inhibits its proinflammatory activity, making it a valuable therapeutic option for treating autoimmune diseases like rheumatoid arthritis, ankylosing spondylitis, and psoriasis.
3. Abatacept (Orencia): A fusion protein consisting of the extracellular domain of cytotoxic T-lymphocyte antigen 4 (CTLA-4) linked to the Fc region of an immunoglobulin, which downregulates T-cell activation and proliferation in autoimmune diseases like rheumatoid arthritis.
4. Belimumab (Benlysta): A monoclonal antibody that targets B-lymphocyte stimulator (BLyS) protein, preventing its interaction with the B-cell surface receptor and inhibiting B-cell activation in systemic lupus erythematosus (SLE).
5. Romiplostim (Nplate): A fusion protein consisting of a thrombopoietin receptor agonist peptide linked to an immunoglobulin Fc region, which stimulates platelet production in patients with chronic immune thrombocytopenia (ITP).
6. Darbepoetin alfa (Aranesp): A hyperglycosylated erythropoiesis-stimulating protein that functions as a longer-acting form of recombinant human erythropoietin, used to treat anemia in patients with chronic kidney disease or cancer.
7. Palivizumab (Synagis): A monoclonal antibody directed against the F protein of respiratory syncytial virus (RSV), which prevents RSV infection and is administered prophylactically to high-risk infants during the RSV season.
8. Ranibizumab (Lucentis): A recombinant humanized monoclonal antibody fragment that binds and inhibits vascular endothelial growth factor A (VEGF-A), used in the treatment of age-related macular degeneration, diabetic retinopathy, and other ocular disorders.
9. Cetuximab (Erbitux): A chimeric monoclonal antibody that binds to epidermal growth factor receptor (EGFR), used in the treatment of colorectal cancer and head and neck squamous cell carcinoma.
10. Adalimumab (Humira): A fully humanized monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), used in the treatment of various inflammatory diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease.
11. Bevacizumab (Avastin): A recombinant humanized monoclonal antibody that binds to VEGF-A, used in the treatment of various cancers, including colorectal, lung, breast, and kidney cancer.
12. Trastuzumab (Herceptin): A humanized monoclonal antibody that targets HER2/neu receptor, used in the treatment of breast cancer.
13. Rituximab (Rituxan): A chimeric monoclonal antibody that binds to CD20 antigen on B cells, used in the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis.
14. Palivizumab (Synagis): A humanized monoclonal antibody that binds to the F protein of respiratory syncytial virus, used in the prevention of respiratory syncytial virus infection in high-risk infants.
15. Infliximab (Remicade): A chimeric monoclonal antibody that targets TNF-α, used in the treatment of various inflammatory diseases, including Crohn's disease, ulcerative colitis, rheumatoid arthritis, and ankylosing spondylitis.
16. Natalizumab (Tysabri): A humanized monoclonal antibody that binds to α4β1 integrin, used in the treatment of multiple sclerosis and Crohn's disease.
17. Adalimumab (Humira): A fully human monoclonal antibody that targets TNF-α, used in the treatment of various inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis.
18. Golimumab (Simponi): A fully human monoclonal antibody that targets TNF-α, used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
19. Certolizumab pegol (Cimzia): A PEGylated Fab' fragment of a humanized monoclonal antibody that targets TNF-α, used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease.
20. Ustekinumab (Stelara): A fully human monoclonal antibody that targets IL-12 and IL-23, used in the treatment of psoriasis, psoriatic arthritis, and Crohn's disease.
21. Secukinumab (Cosentyx): A fully human monoclonal antibody that targets IL-17A, used in the treatment of psoriasis, psoriatic arthritis, and ankylosing spondylitis.
22. Ixekizumab (Taltz): A fully human monoclonal antibody that targets IL-17A, used in the treatment of psoriasis and psoriatic arthritis.
23. Brodalumab (Siliq): A fully human monoclonal antibody that targets IL-17 receptor A, used in the treatment of psoriasis.
24. Sarilumab (Kevzara): A fully human monoclonal antibody that targets the IL-6 receptor, used in the treatment of rheumatoid arthritis.
25. Tocilizumab (Actemra): A humanized monoclonal antibody that targets the IL-6 receptor, used in the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, and chimeric antigen receptor T-cell-induced cytokine release syndrome.
26. Siltuximab (Sylvant): A chimeric monoclonal antibody that targets IL-6, used in the treatment of multicentric Castleman disease.
27. Satralizumab (Enspryng): A humanized monoclonal antibody that targets IL-6 receptor alpha, used in the treatment of neuromyelitis optica spectrum disorder.
28. Sirukumab (Plivensia): A human monoclonal antibody that targets IL-6, used in the treatment

Protein conformation refers to the specific three-dimensional shape that a protein molecule assumes due to the spatial arrangement of its constituent amino acid residues and their associated chemical groups. This complex structure is determined by several factors, including covalent bonds (disulfide bridges), hydrogen bonds, van der Waals forces, and ionic bonds, which help stabilize the protein's unique conformation.

Protein conformations can be broadly classified into two categories: primary, secondary, tertiary, and quaternary structures. The primary structure represents the linear sequence of amino acids in a polypeptide chain. The secondary structure arises from local interactions between adjacent amino acid residues, leading to the formation of recurring motifs such as α-helices and β-sheets. Tertiary structure refers to the overall three-dimensional folding pattern of a single polypeptide chain, while quaternary structure describes the spatial arrangement of multiple folded polypeptide chains (subunits) that interact to form a functional protein complex.

Understanding protein conformation is crucial for elucidating protein function, as the specific three-dimensional shape of a protein directly influences its ability to interact with other molecules, such as ligands, nucleic acids, or other proteins. Any alterations in protein conformation due to genetic mutations, environmental factors, or chemical modifications can lead to loss of function, misfolding, aggregation, and disease states like neurodegenerative disorders and cancer.

Trypsin is a proteolytic enzyme, specifically a serine protease, that is secreted by the pancreas as an inactive precursor, trypsinogen. Trypsinogen is converted into its active form, trypsin, in the small intestine by enterokinase, which is produced by the intestinal mucosa.

Trypsin plays a crucial role in digestion by cleaving proteins into smaller peptides at specific arginine and lysine residues. This enzyme helps to break down dietary proteins into amino acids, allowing for their absorption and utilization by the body. Additionally, trypsin can activate other zymogenic pancreatic enzymes, such as chymotrypsinogen and procarboxypeptidases, thereby contributing to overall protein digestion.

Endonucleases are enzymes that cleave, or cut, phosphodiester bonds within a polynucleotide chain, specifically within the same molecule of DNA or RNA. They can be found in all living organisms and play crucial roles in various biological processes, such as DNA replication, repair, and recombination.

Endonucleases can recognize specific nucleotide sequences (sequence-specific endonucleases) or have no sequence preference (non-specific endonucleases). Some endonucleases generate sticky ends, overhangs of single-stranded DNA after cleavage, while others produce blunt ends without any overhang.

These enzymes are widely used in molecular biology techniques, such as restriction digestion, cloning, and genome editing (e.g., CRISPR-Cas9 system). Restriction endonucleases recognize specific DNA sequences called restriction sites and cleave the phosphodiester bonds at or near these sites, generating defined fragment sizes that can be separated by agarose gel electrophoresis. This property is essential for various applications in genetic engineering and biotechnology.

Enzyme activation refers to the process by which an enzyme becomes biologically active and capable of carrying out its specific chemical or biological reaction. This is often achieved through various post-translational modifications, such as proteolytic cleavage, phosphorylation, or addition of cofactors or prosthetic groups to the enzyme molecule. These modifications can change the conformation or structure of the enzyme, exposing or creating a binding site for the substrate and allowing the enzymatic reaction to occur.

For example, in the case of proteolytic cleavage, an inactive precursor enzyme, known as a zymogen, is cleaved into its active form by a specific protease. This is seen in enzymes such as trypsin and chymotrypsin, which are initially produced in the pancreas as inactive precursors called trypsinogen and chymotrypsinogen, respectively. Once they reach the small intestine, they are activated by enteropeptidase, a protease that cleaves a specific peptide bond, releasing the active enzyme.

Phosphorylation is another common mechanism of enzyme activation, where a phosphate group is added to a specific serine, threonine, or tyrosine residue on the enzyme by a protein kinase. This modification can alter the conformation of the enzyme and create a binding site for the substrate, allowing the enzymatic reaction to occur.

Enzyme activation is a crucial process in many biological pathways, as it allows for precise control over when and where specific reactions take place. It also provides a mechanism for regulating enzyme activity in response to various signals and stimuli, such as hormones, neurotransmitters, or changes in the intracellular environment.

Peptides are short chains of amino acid residues linked by covalent bonds, known as peptide bonds. They are formed when two or more amino acids are joined together through a condensation reaction, which results in the elimination of a water molecule and the formation of an amide bond between the carboxyl group of one amino acid and the amino group of another.

Peptides can vary in length from two to about fifty amino acids, and they are often classified based on their size. For example, dipeptides contain two amino acids, tripeptides contain three, and so on. Oligopeptides typically contain up to ten amino acids, while polypeptides can contain dozens or even hundreds of amino acids.

Peptides play many important roles in the body, including serving as hormones, neurotransmitters, enzymes, and antibiotics. They are also used in medical research and therapeutic applications, such as drug delivery and tissue engineering.

Single-strand specific DNA and RNA endonucleases are enzymes that cleave or cut single-stranded DNA or RNA molecules at specific sites, leaving a free 3'-hydroxyl group and a 5'-phosphate group on the resulting fragments. These enzymes recognize and bind to particular nucleotide sequences or structural motifs in single-stranded nucleic acids, making them useful tools for various molecular biology techniques such as DNA and RNA mapping, sequencing, and manipulation.

Examples of single-strand specific endonucleases include S1 nuclease (specific to single-stranded DNA), mung bean nuclease (specific to single-stranded DNA with a preference for 3'-overhangs), and RNase A (specific to single-stranded RNA). These enzymes have distinct substrate specificities, cleavage patterns, and optimal reaction conditions, which should be carefully considered when selecting them for specific applications.

Western blotting is a laboratory technique used in molecular biology to detect and quantify specific proteins in a mixture of many different proteins. This technique is commonly used to confirm the expression of a protein of interest, determine its size, and investigate its post-translational modifications. The name "Western" blotting distinguishes this technique from Southern blotting (for DNA) and Northern blotting (for RNA).

The Western blotting procedure involves several steps:

1. Protein extraction: The sample containing the proteins of interest is first extracted, often by breaking open cells or tissues and using a buffer to extract the proteins.
2. Separation of proteins by electrophoresis: The extracted proteins are then separated based on their size by loading them onto a polyacrylamide gel and running an electric current through the gel (a process called sodium dodecyl sulfate-polyacrylamide gel electrophoresis or SDS-PAGE). This separates the proteins according to their molecular weight, with smaller proteins migrating faster than larger ones.
3. Transfer of proteins to a membrane: After separation, the proteins are transferred from the gel onto a nitrocellulose or polyvinylidene fluoride (PVDF) membrane using an electric current in a process called blotting. This creates a replica of the protein pattern on the gel but now immobilized on the membrane for further analysis.
4. Blocking: The membrane is then blocked with a blocking agent, such as non-fat dry milk or bovine serum albumin (BSA), to prevent non-specific binding of antibodies in subsequent steps.
5. Primary antibody incubation: A primary antibody that specifically recognizes the protein of interest is added and allowed to bind to its target protein on the membrane. This step may be performed at room temperature or 4°C overnight, depending on the antibody's properties.
6. Washing: The membrane is washed with a buffer to remove unbound primary antibodies.
7. Secondary antibody incubation: A secondary antibody that recognizes the primary antibody (often coupled to an enzyme or fluorophore) is added and allowed to bind to the primary antibody. This step may involve using a horseradish peroxidase (HRP)-conjugated or alkaline phosphatase (AP)-conjugated secondary antibody, depending on the detection method used later.
8. Washing: The membrane is washed again to remove unbound secondary antibodies.
9. Detection: A detection reagent is added to visualize the protein of interest by detecting the signal generated from the enzyme-conjugated or fluorophore-conjugated secondary antibody. This can be done using chemiluminescent, colorimetric, or fluorescent methods.
10. Analysis: The resulting image is analyzed to determine the presence and quantity of the protein of interest in the sample.

Western blotting is a powerful technique for identifying and quantifying specific proteins within complex mixtures. It can be used to study protein expression, post-translational modifications, protein-protein interactions, and more. However, it requires careful optimization and validation to ensure accurate and reproducible results.

Heterogeneous Nuclear RNA (hnRNA) is a type of RNA molecule found in the nucleus of eukaryotic cells during the early stages of gene expression. The term "heterogeneous" refers to the diverse range of sizes and structures that these RNAs exhibit, which can vary from several hundred to tens of thousands of nucleotides in length.

HnRNA is transcribed from DNA templates by the enzyme RNA polymerase II and includes both introns (non-coding sequences) and exons (coding sequences) that will eventually be spliced together to form mature mRNA molecules. HnRNA also contains additional sequences, such as 5' cap structures and 3' poly(A) tails, which are added during post-transcriptional processing.

Because hnRNA is a precursor to mature mRNA, it is often used as a marker for transcriptionally active genes. However, not all hnRNA molecules are ultimately processed into mRNA; some may be degraded or converted into other types of RNA, such as microRNAs or long non-coding RNAs.

Overall, hnRNA plays a critical role in the regulation and expression of genes in eukaryotic cells.

Small nucleolar RNAs (snoRNAs) are a specific class of small RNA molecules that range in size from 60 to 300 nucleotides. They are primarily located in the dense granules of the nucleus called nucleoli, which are membrane-less organelles where ribosome biogenesis occurs.

SnoRNAs guide the chemical modification of other RNA molecules, mainly ribosomal RNAs (rRNAs) and small nuclear RNAs (snRNAs). They function as guides for site-specific post-transcriptional modifications, such as 2'-O-methylation and pseudouridination, of their target RNAs. These modifications are essential for the stability, structure, and functionality of the target RNAs.

SnoRNAs can be classified into two main groups based on their secondary structures and sequence motifs:

1. C/D box snoRNAs: These snoRNAs contain conserved sequence motifs known as the C (RUGAUGA) and D (CUGA) boxes, which are located in the 5' and 3' ends of the snoRNA, respectively. They typically guide 2'-O-methylation of their target RNAs.
2. H/ACA box snoRNAs: These snoRNAs contain conserved sequence motifs known as the H (ANANNA) and ACA boxes, which are located in the 5' and 3' ends of the snoRNA, respectively. They typically guide pseudouridination of their target RNAs.

SnoRNAs are encoded by either host genes or as independent transcription units. In some cases, they can be found within introns of protein-coding or non-protein-coding genes and are processed from the primary transcript (pre-mRNA or intron lariat) during splicing.

In summary, small nucleolar RNAs (snoRNAs) are a class of small RNA molecules that guide post-transcriptional modifications, mainly 2'-O-methylation and pseudouridination, of other RNA molecules such as ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs), and messenger RNAs (mRNAs).

5.8S ribosomal RNA (rRNA) is a type of structural RNA molecule that is a component of the large subunit of eukaryotic ribosomes. It is one of the several rRNA species that are present in the ribosome, which also include the 18S rRNA in the small subunit and the 28S and 5S rRNAs in the large subunit. The 5.8S rRNA plays a role in the translation process, where it helps in the decoding of messenger RNA (mRNA) during protein synthesis. It is transcribed from DNA as part of a larger precursor RNA molecule, which is then processed to produce the mature 5.8S rRNA. The length of the 5.8S rRNA varies slightly between species, but it is generally around 160 nucleotides long in humans.

Aspartic acid endopeptidases are a type of enzyme that cleave peptide bonds within proteins. They are also known as aspartyl proteases or aspartic proteinases. These enzymes contain two catalytic aspartic acid residues in their active site, which work together to hydrolyze the peptide bond.

Aspartic acid endopeptidases play important roles in various biological processes, including protein degradation, processing, and activation. They are found in many organisms, including viruses, bacteria, fungi, plants, and animals. Some well-known examples of aspartic acid endopeptidases include pepsin, cathepsin D, and HIV protease.

Pepsin is a digestive enzyme found in the stomach that helps break down proteins in food. Cathepsin D is a lysosomal enzyme that plays a role in protein turnover and degradation within cells. HIV protease is an essential enzyme for the replication of the human immunodeficiency virus (HIV), which causes AIDS. Inhibitors of HIV protease are used as antiretroviral drugs to treat HIV infection.

Cricetinae is a subfamily of rodents that includes hamsters, gerbils, and relatives. These small mammals are characterized by having short limbs, compact bodies, and cheek pouches for storing food. They are native to various parts of the world, particularly in Europe, Asia, and Africa. Some species are popular pets due to their small size, easy care, and friendly nature. In a medical context, understanding the biology and behavior of Cricetinae species can be important for individuals who keep them as pets or for researchers studying their physiology.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

Metalloendopeptidases are a type of enzymes that cleave peptide bonds in proteins, specifically at interior positions within the polypeptide chain. They require metal ions as cofactors for their catalytic activity, typically zinc (Zn2+) or cobalt (Co2+). These enzymes play important roles in various biological processes such as protein degradation, processing, and signaling. Examples of metalloendopeptidases include thermolysin, matrix metalloproteinases (MMPs), and neutrophil elastase.

Small untranslated region (UTR) of RNA refers to the non-coding sequences located at the 5' end (5' UTR) or 3' end (3' UTR) of an mRNA molecule that do not contain information for protein synthesis. These regions play a role in the regulation of translation, stability, and localization of the mRNA. The small untranslated regions are so named because they are typically shorter in length compared to other regulatory elements found within the mRNA.

Membrane proteins are a type of protein that are embedded in the lipid bilayer of biological membranes, such as the plasma membrane of cells or the inner membrane of mitochondria. These proteins play crucial roles in various cellular processes, including:

1. Cell-cell recognition and signaling
2. Transport of molecules across the membrane (selective permeability)
3. Enzymatic reactions at the membrane surface
4. Energy transduction and conversion
5. Mechanosensation and signal transduction

Membrane proteins can be classified into two main categories: integral membrane proteins, which are permanently associated with the lipid bilayer, and peripheral membrane proteins, which are temporarily or loosely attached to the membrane surface. Integral membrane proteins can further be divided into three subcategories based on their topology:

1. Transmembrane proteins, which span the entire width of the lipid bilayer with one or more alpha-helices or beta-barrels.
2. Lipid-anchored proteins, which are covalently attached to lipids in the membrane via a glycosylphosphatidylinositol (GPI) anchor or other lipid modifications.
3. Monotopic proteins, which are partially embedded in the membrane and have one or more domains exposed to either side of the bilayer.

Membrane proteins are essential for maintaining cellular homeostasis and are targets for various therapeutic interventions, including drug development and gene therapy. However, their structural complexity and hydrophobicity make them challenging to study using traditional biochemical methods, requiring specialized techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and single-particle cryo-electron microscopy (cryo-EM).

Promoter regions in genetics refer to specific DNA sequences located near the transcription start site of a gene. They serve as binding sites for RNA polymerase and various transcription factors that regulate the initiation of gene transcription. These regulatory elements help control the rate of transcription and, therefore, the level of gene expression. Promoter regions can be composed of different types of sequences, such as the TATA box and CAAT box, and their organization and composition can vary between different genes and species.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a laboratory technique used in molecular biology to amplify and detect specific DNA sequences. This technique is particularly useful for the detection and quantification of RNA viruses, as well as for the analysis of gene expression.

The process involves two main steps: reverse transcription and polymerase chain reaction (PCR). In the first step, reverse transcriptase enzyme is used to convert RNA into complementary DNA (cDNA) by reading the template provided by the RNA molecule. This cDNA then serves as a template for the PCR amplification step.

In the second step, the PCR reaction uses two primers that flank the target DNA sequence and a thermostable polymerase enzyme to repeatedly copy the targeted cDNA sequence. The reaction mixture is heated and cooled in cycles, allowing the primers to anneal to the template, and the polymerase to extend the new strand. This results in exponential amplification of the target DNA sequence, making it possible to detect even small amounts of RNA or cDNA.

RT-PCR is a sensitive and specific technique that has many applications in medical research and diagnostics, including the detection of viruses such as HIV, hepatitis C virus, and SARS-CoV-2 (the virus that causes COVID-19). It can also be used to study gene expression, identify genetic mutations, and diagnose genetic disorders.

"Small cytoplasmic RNAs" (scRNAs) are a heterogeneous group of non-coding RNA molecules that are typically 100-300 nucleotides in length and are located within the cytoplasm of cells. They play various roles in post-transcriptional regulation of gene expression, including serving as components of ribonucleoprotein complexes involved in mRNA splicing, stability, and translation.

Some specific types of scRNAs include small nuclear RNAs (snRNAs), which are involved in spliceosomal complexes that remove introns from pre-mRNA; small nucleolar RNAs (snoRNAs), which guide chemical modifications of other RNA molecules, such as ribosomal RNAs (rRNAs); and microRNAs (miRNAs), which bind to target mRNAs and inhibit their translation or promote their degradation.

It's worth noting that the term "small cytoplasmic RNA" is a broad category, and individual scRNAs can have distinct functions and characteristics.

'Escherichia coli (E. coli) proteins' refer to the various types of proteins that are produced and expressed by the bacterium Escherichia coli. These proteins play a critical role in the growth, development, and survival of the organism. They are involved in various cellular processes such as metabolism, DNA replication, transcription, translation, repair, and regulation.

E. coli is a gram-negative, facultative anaerobe that is commonly found in the intestines of warm-blooded organisms. It is widely used as a model organism in scientific research due to its well-studied genetics, rapid growth, and ability to be easily manipulated in the laboratory. As a result, many E. coli proteins have been identified, characterized, and studied in great detail.

Some examples of E. coli proteins include enzymes involved in carbohydrate metabolism such as lactase, sucrase, and maltose; proteins involved in DNA replication such as the polymerases, single-stranded binding proteins, and helicases; proteins involved in transcription such as RNA polymerase and sigma factors; proteins involved in translation such as ribosomal proteins, tRNAs, and aminoacyl-tRNA synthetases; and regulatory proteins such as global regulators, two-component systems, and transcription factors.

Understanding the structure, function, and regulation of E. coli proteins is essential for understanding the basic biology of this important organism, as well as for developing new strategies for combating bacterial infections and improving industrial processes involving bacteria.

Complementary DNA (cDNA) is a type of DNA that is synthesized from a single-stranded RNA molecule through the process of reverse transcription. In this process, the enzyme reverse transcriptase uses an RNA molecule as a template to synthesize a complementary DNA strand. The resulting cDNA is therefore complementary to the original RNA molecule and is a copy of its coding sequence, but it does not contain non-coding regions such as introns that are present in genomic DNA.

Complementary DNA is often used in molecular biology research to study gene expression, protein function, and other genetic phenomena. For example, cDNA can be used to create cDNA libraries, which are collections of cloned cDNA fragments that represent the expressed genes in a particular cell type or tissue. These libraries can then be screened for specific genes or gene products of interest. Additionally, cDNA can be used to produce recombinant proteins in heterologous expression systems, allowing researchers to study the structure and function of proteins that may be difficult to express or purify from their native sources.

Transcription factors are proteins that play a crucial role in regulating gene expression by controlling the transcription of DNA to messenger RNA (mRNA). They function by binding to specific DNA sequences, known as response elements, located in the promoter region or enhancer regions of target genes. This binding can either activate or repress the initiation of transcription, depending on the properties and interactions of the particular transcription factor. Transcription factors often act as part of a complex network of regulatory proteins that determine the precise spatiotemporal patterns of gene expression during development, differentiation, and homeostasis in an organism.

Uridine is a nucleoside that consists of a pyrimidine base (uracil) linked to a pentose sugar (ribose). It is a component of RNA, where it pairs with adenine. Uridine can also be found in various foods such as beer, broccoli, yeast, and meat. In the body, uridine can be synthesized from orotate or from the breakdown of RNA. It has several functions, including acting as a building block for RNA, contributing to energy metabolism, and regulating cell growth and differentiation. Uridine is also available as a dietary supplement and has been studied for its potential benefits in various health conditions.

A cell line that is derived from tumor cells and has been adapted to grow in culture. These cell lines are often used in research to study the characteristics of cancer cells, including their growth patterns, genetic changes, and responses to various treatments. They can be established from many different types of tumors, such as carcinomas, sarcomas, and leukemias. Once established, these cell lines can be grown and maintained indefinitely in the laboratory, allowing researchers to conduct experiments and studies that would not be feasible using primary tumor cells. It is important to note that tumor cell lines may not always accurately represent the behavior of the original tumor, as they can undergo genetic changes during their time in culture.

Cytoplasm is the material within a eukaryotic cell (a cell with a true nucleus) that lies between the nuclear membrane and the cell membrane. It is composed of an aqueous solution called cytosol, in which various organelles such as mitochondria, ribosomes, endoplasmic reticulum, Golgi apparatus, lysosomes, and vacuoles are suspended. Cytoplasm also contains a variety of dissolved nutrients, metabolites, ions, and enzymes that are involved in various cellular processes such as metabolism, signaling, and transport. It is where most of the cell's metabolic activities take place, and it plays a crucial role in maintaining the structure and function of the cell.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

Viral nonstructural proteins (NS) are viral proteins that are not part of the virion structure. They play various roles in the viral life cycle, such as replication of the viral genome, transcription, translation regulation, and modulation of the host cell environment to favor virus replication. These proteins are often produced in large quantities during infection and can manipulate or disrupt various cellular pathways to benefit the virus. They may also be involved in evasion of the host's immune response. The specific functions of viral nonstructural proteins vary depending on the type of virus.

Ribonuclease P (RNase P) is an endonuclease enzyme complex that is found in all three domains of life: archaea, bacteria, and eukaryotes. Its primary function is to process precursor transfer RNA (tRNA) molecules by cleaving the 5' leader sequence to generate mature tRNAs.

RNase P is unique because it consists of both a protein component and an RNA subunit, known as the RNA moiety or RNA catalytic subunit. In bacteria and archaea, the RNA subunit is primarily responsible for the enzymatic activity, while in eukaryotes, the protein component plays a more significant role.

RNase P's function in tRNA processing is essential for protein synthesis, as mature tRNAs are necessary for decoding messenger RNA (mRNA) sequences and translating them into proteins during translation. Dysregulation or mutations in RNase P can lead to various human diseases, including mitochondrial disorders, neurodevelopmental abnormalities, and cancer.

... untranslated region of a newly synthesized pre-messenger RNA (mRNA) molecule in the process of gene transcription. The cleavage ... Cleavage factors are two closely associated protein complexes involved in the cleavage of the 3' ... The proteins that constitute these complexes are recruited to the cleavage site by cleavage and polyadenylation specificity ... It is composed of only two proteins: PCF11 CLP1 Hardy, J. G.; Norbury, C. J. (15 August 2016). "Cleavage factor Im (CFIm) as a ...
... to cleavage of transfer RNA; and to interference with the NF-κB pathway. Currently (as of March 2020) Ranpirnase is in clinical ... The mechanism of action of ranpirnase has been attributed to the RNA interference pathway, potentially through cleaving siRNA ... Zhao H, Ardelt B, Ardelt W, Shogen K, Darzynkiewicz Z (October 2008). "The cytotoxic ribonuclease onconase targets RNA ... protein superfamily and degrades RNA substrates with a sequence preference for uracil and guanine nucleotides. Along with ...
Donis-Keller, Helen (1979). "Site specific enzymatic cleavage of RNA". Nucleic Acids Research. 7 (1): 179-192. doi:10.1093/nar/ ... Donis-Keller, Helen (1980). "Phy M: an RNase activity specific for U and A residues useful in RNA sequence analysis". Nucleic ... Donis-Keller's graduate research established a method to do RNA sequencing. During her time at Collaborative Research, her ... Donis-Keller, Helen; Maxam, Allan M.; Gilbert, Walter (1977). "Mapping adenines, guanines, and pyrimidines in RNA". Nucleic ...
The Beta-globin co-transcriptional cleavage ribozyme (CotC ribozyme) was proposed to be an RNA enzyme known as a ribozyme. ... Dye MJ, Proudfoot NJ (2001). "Multiple transcript cleavage precedes polymerase release intermination by RNA polymerase II". ... "Autocatalytic RNA cleavage in the human beta-globin pre-mRNA promotestranscription termination". Nature. 432 (7016): 526-530. ... Non-coding RNA, Ribozymes, RNA splicing, All stub articles, Molecular and cellular biology stubs, Chemical reaction stubs, ...
doi:10.1261/rna.079397.122. ISSN 1355-8382. PMC 9745839. PMID 36113877. Altman, Sidney. "ENZYMATIC CLEAVAGE OF RNA BY RNA" (PDF ... Reed also studied the spliceosome, a multi-component RNA machine. The U2 spliceosomal RNA (U2 snRNA), is the target of the anti ... For her PhD, she worked in the laboratory of Sidney Altman and was the first to clone and sequence the RNA gene. Altman ... She showed that E7107 causes defects in the assembly of spliceosomes and stops tight binding of U2 spliceosomal RNA. She ...
RNase A is another enzyme that catalyzes the cleavage of the P-O5' bond of RNA specifically after pyrimidine residues, which is ... The mechanism would end at intron cleavage. This is regulator is thought to limit or interfere with the continuation of RNA ... Xue S, Calvin K, Li H (May 2006). "RNA recognition and cleavage by a splicing endonuclease". Science. 312 (5775): 906-910. ... After cleavage of the two sites, three fragments result: a 3'-half-tRNA molecule with a 5'-OH end, a 5'-half-tRNA molecule with ...
... small nuclear RNA (snRNA) and small nucleolar RNA (snoRNA). The basic dsRNA cleavage function of Class 1 RNase III is retained ... "Ribonuclease III mechanisms of double-stranded RNA cleavage". Wiley Interdisciplinary Reviews: RNA. 5 (1): 31-48. doi:10.1002/ ... They are ubiquitous compounds in the cell and play a major role in pathways such as RNA precursor synthesis, RNA Silencing, and ... RNAs that are produced by Dicer act as guides for a sequence of particular silencing of cognate genes through RNAi and related ...
In an additional approach, dubbed small-molecule nucleic acid profiling by cleavage applied to RNA (Ribo-SNAP) showed that ... RNA Complexation That Target the RNA: Specific Recognition of Human Immunodeficiency Virus Type 1 TAR RNA by Small Organic ... Guan, Lirui; Disney, Matthew D (2013). "Small-Molecule-Mediated Cleavage of RNA in Living Cells". Angewandte Chemie ... Additionally, HIV-1 RNA has been targeted extensively in vitro by RNA-binding small molecules. In 2007, Miller and coworkers ...
Davies, Julian E.; Schindler, Daniel G. (1977-04-01). "Specific cleavage of ribosomal RNA caused by alpha sarcin". Nucleic ... This cleavage leads to cell death by apoptosis. However, since they are extracellular proteins, they must first enter the cells ... Ribotoxins cleave RNA following a general acid-base mechanism shared by all the extracellular fungal RNases so far ... doi:10.1007/978-94-007-6728-7_16-3. ISBN 978-94-007-6728-7. Tsurugi, K.; Endo, Y. (1987-06-15). "RNA N-glycosidase activity of ...
They enable the cleavage, insertion, and deletion of bases. Trypanosomatid protists and other kinetoplastids have a novel post- ... Guide RNAs binds to the anti sense RNA sequence and regulates the RNA modification. It is observed that small interfering RNA ( ... A guide RNA (gRNA) is a piece of RNA that functions as a guide for RNA- or DNA-targeting enzymes, with which it forms complexes ... Guide RNAs are the small nucleolar RNA, these along with riboproteins perform intracellular RNA alterations such as ...
... resulting in ester cleavage of the RNA backbone. (This mechanism is also referred to as RNA cleavage.) This produces a 2',3'- ... This process is known as an auto-hydrolysis or a self-cleavage reaction. Spontaneous cleavage in an RNA molecule is much more ... RNA hydrolysis is a reaction in which a phosphodiester bond in the sugar-phosphate backbone of RNA is broken, cleaving the RNA ... When the RNA is double-stranded or involved in nucleotide base pairing, it is more stable and spontaneous cleavage is ...
The protein encoded by this gene is one subunit of the cleavage factor Im complex required for 3' RNA cleavage and ... Awasthi S, Alwine JC (2003). "Association of polyadenylation cleavage factor I with U1 snRNP". RNA. 9 (11): 1400-9. doi:10.1261 ... 2005). "Distinct sequence motifs within the 68-kDa subunit of cleavage factor Im mediate RNA binding, protein-protein ... 2000). "Human pre-mRNA cleavage factor IIm contains homologs of yeast proteins and bridges two other cleavage factors". EMBO J ...
Internal guide RNA interactions interfere with Cas9-mediated cleavage. Nature Communications 7, 11750. McKenna, A., Findlay, G. ... "Ribosome profiling reveals resemblance between long non-coding RNAs and 5′ leaders of coding RNAs". Development. 140 (13): 2828 ... Schier AF (2007). "The Maternal-Zygotic Transition: Death and Birth of RNAs". Science 316 (5823): 406-7. Giraldez, A.J., ... chromatin and non-coding RNAs. Schier's more recent interest in behavior has established zebrafish as a model for sleep and ...
The granzymes bind directly to the nucleic acids DNA and RNA; this enhances their cleavage of nucleic acid binding proteins. ... June 2014). "Leukocyte protease binding to nucleic acids promotes nuclear localization and cleavage of nucleic acid binding ... December 2011). "Granzyme B inhibits vaccinia virus production through proteolytic cleavage of eukaryotic initiation factor 4 ...
Removal of 3´ and 5´ extensions from DNA or RNA termini. Transcriptional mapping. Cleavage of hairpin loops. Excision of gene ... double-stranded RNA, or DNA / RNA hybrids. Mung Bean Nuclease catalyzes the specific degradation of single-stranded DNA or RNA ... An excess of the enzyme is required to degrade double-stranded DNA or RNA and DNA-RNA hybrids, and in this case, AT-rich ... Cleavage of single-basepair mismatches, as a replacement for CEL 1 Nuclease in TILLING. Unidirectional deletion of large DNA ( ...
Han BW, Wang W, Li C, Weng Z, Zamore PD (May 2015). "Noncoding RNA. piRNA-guided transposon cleavage initiates Zucchini- ... Piwi-interacting RNA (piRNA) is the largest class of small non-coding RNA molecules expressed in animal cells. piRNAs form RNA- ... piRNA has a role in RNA silencing via the formation of an RNA-induced silencing complex (RISC). piRNAs interact with piwi ... Ozata DM, Gainetdinov I, Zoch A, Phillip D, Zamore PD (2019). "PIWI-interacting RNAs: small RNAs with big functions" (PDF). ...
Thus, U1 snRNA-pre-mRNA base pairing was shown to protect pre-mRNA from polyadenylation as well as premature cleavage. This ... U1 spliceosomal RNA, U2 spliceosomal RNA, U4 spliceosomal RNA, U5 spliceosomal RNA, and U6 spliceosomal RNA. Their nomenclature ... These are small RNA molecules that play an essential role in RNA biogenesis and guide chemical modifications of ribosomal RNAs ... They have also been shown to aid in the regulation of transcription factors (7SK RNA) or RNA polymerase II (B2 RNA), and ...
"Single-stranded antisense siRNAs guide target RNA cleavage in RNAi". Cell. 110 (5): 563-74. doi:10.1016/S0092-8674(02)00908-X. ... Doi N, Zenno S, Ueda R, Ohki-Hamazaki H, Ui-Tei K, Saigo K (Jan 2003). "Short-interfering-RNA-mediated gene silencing in ... This gene encodes a member of the Argonaute family of proteins which play a role in RNA interference. The encoded protein is ... It may interact with dicer1 and play a role in short-interfering-RNA-mediated gene silencing. This gene is located on ...
Zamore PD, Tuschl T, Sharp PA, Bartel DP (2000). "RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to ... RNA-induced transcriptional silencing (RITS) RNA interference Pratt AJ, MacRae IJ (2009). "The RNA-induced silencing complex: A ... RNA. 11 (5): 674-682. doi:10.1261/rna.7272305. PMC 1370754. PMID 15811921. Hutvagner, Gyorgy (2005). "Small RNA asymmetry in ... There are eight family members in human Argonautes of which only Argonaute 2 is exclusively involved in targeted RNA cleavage ...
Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T (Jul 2004). "Human Argonaute2 mediates RNA cleavage ... Argonaute Piwi siRNA RNA interference RNA-induced silencing complex RNA-dependent RNA polymerase Tabara, H.; Sarkissian, M.; ... The primary Argonaute complex recruits an RNA-dependent RNA polymerase (RdRP) to generate secondary siRNAs, triggering an ... However, RDE-1 has not been implicated in mRNA-cleavage activity. Instead, RDE-1 with mutations in the conserved DDH motif ...
End Cleavage of Target RNAs". Cell Reports. 27 (5): 1397-1408.e4. doi:10.1016/j.celrep.2019.04.008. PMC 6661904. PMID 31042468 ... RNAs are selected based on USER codes, or cis-acting elements, within their RNAs for specific levels of RNA processing; thus ... In vitro, VPg-RNA conjugates were translated with similar efficiency to m7G-capped RNAs indicating that VPg binds eIF4E and ... Its multiple roles in RNA processing require its association of RNAs through the m7G cap, and thus eIF4E can be considered a ...
Northern blot analysis also indicated this RNA undergoes specific cleavage processing. The GlmZ sRNA has been shown to ... Page for SraJ RNA at Rfam v t e (Articles with short description, Short description matches Wikidata, Non-coding RNA, All stub ... "Targeted decay of a regulatory small RNA by an adaptor protein for RNase E and counteraction by an anti-adaptor RNA". Genes & ... GlmZ (formally known as SraJ) is a small non-coding RNA (ncRNA). It is the functional product of a gene which is not translated ...
"Reversible Photocontrol of Deoxyribozyme-Catalyzed RNA Cleavage under Multiple-Turnover Conditions". Angewandte Chemie ...
"RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage". Genes & Development. 24 (15): 1590-5. doi: ... RNA. 14 (8): 1663-70. doi:10.1261/rna.970408. PMC 2491481. PMID 18567810. Schaefer M, Pollex T, Hanna K, Tuorto F, Meusburger M ...
They directly base-pair to target messenger RNAs (mRNAs), and can trigger cleavage of the mRNA depending on the degree of ... Circular RNA (or circRNA) is a type of single-stranded RNA which, unlike linear RNA, forms a covalently closed continuous loop ... RNAs can undergo base modification by RNA editing after transcription. RNA editing occurs mainly in Alu elements of protein- ... February 2013). "Circular RNAs are abundant, conserved, and associated with ALU repeats". RNA. 19 (2): 141-157. doi:10.1261/rna ...
... most part of a newly produced RNA and polyadenylates the end produced by this cleavage. The cleavage is catalysed by the enzyme ... The 3′ end is also where the poly(A) tail is found on polyadenylated RNAs. Messenger RNA (mRNA) is RNA that has a coding region ... But, for many long noncoding RNAs - a seemingly large group of regulatory RNAs that, for example, includes the RNA Xist, which ... The rate of deadenylation may also be regulated by RNA-binding proteins. Additionally, RNA triple helix structures and RNA ...
Prior to cleavage by exo- and endonucleases, the pre-rRNA undergoes a complex pattern of nucleoside modifications. These ... SnoRNAs are commonly referred to as guide RNAs but should not be confused with the guide RNAs that direct RNA editing in ... mainly ribosomal RNAs, transfer RNAs and small nuclear RNAs. There are two main classes of snoRNA, the C/D box snoRNAs, which ... doi:10.1261/rna.1354009. PMC 2648702. PMID 19095616. Jády BE, Kiss T (February 2001). "A small nucleolar guide RNA functions ...
"Entrez Gene: CSTF1 cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa". Kleiman FE, Manley JL (September 1999). " ... Cleavage stimulation factor 50 kDa subunit is a protein that in humans is encoded by the CSTF1 gene. This gene encodes one of ... Rüegsegger U, Beyer K, Keller W (March 1996). "Purification and characterization of human cleavage factor Im involved in the 3 ... Murthy KG, Manley JL (November 1995). "The 160-kD subunit of human cleavage-polyadenylation specificity factor coordinates pre- ...
Okamura K, Ishizuka A, Siomi H, Siomi M (2004). "Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage ... Ahlquist P (May 2002). "RNA-dependent RNA polymerases, viruses, and RNA silencing". Science. 296 (5571): 1270-3. Bibcode: ... "Double-stranded RNA binding may be a general plant RNA viral strategy to suppress RNA silencing". Journal of Virology. 80 (12 ... Zamore PD, Tuschl T, Sharp PA, Bartel DP (March 2000). "RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at ...
The twister ribozyme is a catalytic RNA structure capable of self-cleavage. The nucleolytic activity of this ribozyme has been ... Replacements of the pro-S nonbridging oxygen of the scissile phosphate with a thiol group leads to reduced self-cleavage rates ... In contrast to in vitro selection methods, which have aided in identifying several classes of catalytic RNA motifs, the twister ... Eiler, Daniel; Wang, Jimin; Steitz, Thomas A. (2014-09-09). "Structural basis for the fast self-cleavage reaction catalyzed by ...
... . World J Gastroenterol 2002; 8(1): 91-94 ... Anti-HBV hairpin ribozyme-mediated cleavage of target RNA in vitro. . World J Gastroenterol 2002; 8(1): 91-94 [PMID: 11833079 ... Figure 5 Time curves of cleavage reactions of HpRz prepared in vitro. ...
"RNA Cleavage" by people in this website by year, and whether "RNA Cleavage" was a major or minor topic of these publications. ... "RNA Cleavage" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... Below are the most recent publications written about "RNA Cleavage" by people in Profiles. ... Below are MeSH descriptors whose meaning is more general than "RNA Cleavage". ...
In particular, the RNA interference (RNAi) pathways are of notable significance for the control of viral infections. Although ... The size and characteristics of these small RNAs indicate that both the siRNA and piRNA pathways are induced in response to ... As observed in vector mosquito species, small RNAs are produced that target viral sequences. ... Ago2 uses the other strand to recognize complementary viral RNA, which leads to the cleavage and degradation of the target ...
There are multiple published methods for strand-specific RNA-seq, but no consensus exists as to how to choose between them. ... Here we developed a comprehensive computational pipeline to compare library quality metrics from any RNA-seq method. Using the ... Weighing each methods performance and ease, we identified the dUTP second-strand marking and the Illumina RNA ligation methods ... They provide a computational pipeline to compare these metrics from any RNA-seq protocol. Strand-specific, massively parallel ...
We show that both binding and cleavage of DNA by Cas9-RNA require recognition of a short trinucleotide protospacer adjacent ... associated enzyme Cas9 is an RNA-guided endonuclease that uses RNA-DNA base-pairing to target foreign DNA in bacteria. Cas9- ... and sequences fully complementary to the guide RNA but lacking a nearby PAM are ignored by Cas9-RNA. Competition assays provide ... In addition to its relevance for gene manipulation, this work reveals how DNA is interrogated by Cas9-RNA in its role as an ...
RNA was extracted by using QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA). FCoV primers that detect most circulating ... Fluorogenic Peptide Furin Cleavage Assay. Figure 4. Figure 4. . Furin cleavage assays of fluorogenic peptides. A) Synthetic ... This is corroborated by our peptide cleavage data that demonstrate that furin cleavage is fully abrogated for all P1 ... de Haan CAM, Haijema BJ, Schellen P, Schreur PW, te Lintelo E, Vennema H, Cleavage of group 1 coronavirus spike proteins: how ...
... ... RNA-targeting CRISPR effectorCRISPRRNA BiologyRepeat expansion diseasesCRISPR-Cas13CRISPR-Csm ... RNA imaging, RNA editing, and so on. Be that as it may, the precise biochemical mechanisms of these systems remain elusive and ... In this study, we applied advanced techniques to examine the cleavage sites of CasRx in vitro and in vivo. With the bind-and- ...
... untranslated region of a newly synthesized pre-messenger RNA (mRNA) molecule in the process of gene transcription. The cleavage ... Cleavage factors are two closely associated protein complexes involved in the cleavage of the 3 ... The proteins that constitute these complexes are recruited to the cleavage site by cleavage and polyadenylation specificity ... It is composed of only two proteins: PCF11 CLP1 Hardy, J. G.; Norbury, C. J. (15 August 2016). "Cleavage factor Im (CFIm) as a ...
ROLE OF DIVALENT METAL-IONS IN THE HAMMERHEAD RNA CLEAVAGE REACTION Journal Article *Overview ...
... RNA. 2008 Feb;14(2):233-9. doi ... The cleavage mechanism is similar to that in bacteria, showing the feasibility of A-site cleavage of mRNA for regulatory ... DOI: 10.1261/rna.693208 Abstract RelE/RelB is a well-characterized toxin-anti-toxin pair involved in nutritional stress ... 10.1261/rna.693208. Epub 2007 Dec 14. Authors Dmitri Andreev 1 , Vasili Hauryliuk, Ilya Terenin, Sergey Dmitriev, Måns ...
keywords = "28S ribosomal RNA (rRNA), Cell death-associated RNA cleavage, Postmortem interval (PMI), RNA degrada", ... Cell death-associated ribosomal RNA cleavage in postmortem tissues and its forensic applications. In: Molecules and Cells. 2017 ... Cell death-associated ribosomal RNA cleavage in postmortem tissues and its forensic applications. Molecules and Cells. 2017 Jan ... We found that the D8 divergent domain of ribosomal RNA (rRNA) bearing cell death-related cleavage sites was rapidly removed ...
Dive into the research topics of Characterization of mazF-mediated sequence-specific RNA cleavage in pseudomonas putida using ... Characterization of mazF-mediated sequence-specific RNA cleavage in pseudomonas putida using massive parallel sequencing. ...
... on intracellular cleavage kinetics. H1 is the base-paired helix formed between ribozyme and 3 cleavage product RNAs. H1 ... The kinetic mechanism of the hairpin ribozyme in vivo: influence of RNA helix stability on intracellular cleavage kinetics. ... cleavage activity in yeast to learn how structure-function relationships defined for RNA enzymes in vitro relate to RNA- ... Consequently, ribozymes with stable H1 sequences display sharply reduced self-cleavage rates, because cleavage is reversed by ...
... Preprint ... 2020). Topoisomerase 3B (TOP3B) DNA and RNA Cleavage Complexes and Pathway to Repair TOP3B-Linked RNA and DNA Breaks . 10.2139/ ... 2020). Topoisomerase 3B (TOP3B) DNA and RNA Cleavage Complexes and Pathway to Repair TOP3B-Linked RNA and DNA Breaks . 10.2139/ ...
A calix[4]arene with acylguanidine units as an efficient catalyst for phosphodiester bond cleavage in RNA and DNA model ... A calix[4]arene with acylguanidine units as an efficient catalyst for phosphodiester bond cleavage in RNA and DNA model ... A calix[4]arene with acylguanidine units as an efficient catalyst for phosphodiester bond cleavage in RNA and DNA model ... effectively catalyzes the cleavage of phosphodiester bonds of HPNP and BNPP under neutral pH conditions. The catalyst ...
A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of ... A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of ...
These novel bioinformatic methods have been combined with enzymic mapping of RNA transcripts from the core and NS5B regions to ... that analyses multiple rna-folding patterns predicted by mfold to determine the evolutionary conservation of predicted stem- ... loop structures and, by a new method, to analyse frequencies of covariant sites in predicted RNA folding between HCV genotypes ... a structural configuration of the genomes of many positive-stranded RNA viruses that is associated with host persistence. ...
HEPN nucleases participate in diverse RNA cleavage pathwa … ... Keywords: LAS1L; Las1; Las1L; RNA cleavage; RNA degradation; ... important for RNA cleavage. Most HEPN nucleases participate in stress-activated RNA cleavage pathways; Las1 plays a fundamental ... HEPN nucleases participate in diverse RNA cleavage pathways and share a short HEPN nuclease motif (RφXXXH) ... Using reconstituted Las1 HEPN-HEPN chimeras, we defined the molecular requirements for RNA cleavage. Intriguingly, both copies ...
The CRISPR/Cas system uses guide RNAs (gRNAs) to direct sequence-specific DNA cleavage. Not every gRNA elicits cleavage and the ... Internal guide RNA interactions interfere with Cas9-mediated cleavage  Thyme, Summer B.; Akhmetova, Laila; Montague, Tessa G. ... but spatial RNA assays traditionally rely on staining for a limited number of RNA species. In contrast, single-cell RNA-seq ... single-strand RNA-DNA hybrids that induce catalytic degradation of complementary cellular RNAs via RNase H. ASOs are widely ...
2007 - Royal Society Research Grant; "Investigation of cleavage reactions by RNA polymerase" (PI; £15K) ... Yuzenkova Y., Zenkin N*. (2010) Central role of the RNA polymerase trigger loop in intrinsic RNA hydrolysis PROC NATL ACAD SCI ... and Severinov K. Regulation of RNA polymerase through its active center. In: Buc, H., and Strick, T. ed. RNA polymerases as ... Yuzenkova Y, Zenkin N. Central role of the RNA polymerase trigger loop in intrinsic RNA hydrolysis. Proceedings of the National ...
Distinct roles for Argonaute proteins in small RNA- directed RNA cleavage pathways.Genes & Development 18. 1655. 1666. Hamilton ... 7SK RNA) or RNA polimerase II (B2 RNA) and maintaining the telomeres [69]. RNA-RNA interactions between snRNAs or between ... RNA editing of miRNA precursor. RNA 10. 1174. 1177. *99. Gott. J. M.. Emerson. R. B.. 2000. Functions and mechanisms of RNA ... small nuclear RNA (snRNAs), Small nucleolar RNAs(snoRNAs), piwi- interacting RNAs (piRNAs) and long nc RNA (lncRNA) 200-2800 nt ...
Quantitative studies of Mn2+-promoted specific and non-specific cleavages of a large RNA: Mn2+-GAAA ribozymes and the evolution ... Dive into the research topics of Quantitative studies of Mn2+-promoted specific and non-specific cleavages of a large RNA: Mn ...
Programmable RNA recognition and cleavage by CRISPR/Cas9.﻽. OConnell MR, Oakes BL, Sternberg SH, East-Seletsky A, Kaplan M, ... Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.﻽. East-Seletsky A, OConnell MR, ... Programmable RNA Tracking in Live Cells with CRISPR/Cas9.﻽. Nelles DA, Fang MY, OConnell MR, Xu JL, Markmiller SJ, Doudna JA, ... RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a.﻽. Tambe A, East-Seletsky A, Knott GJ, Doudna JA, ...
Total RNA was isolated using Trizol RNA extraction. Small RNAs were subsequently purified from total RNA using the Zymo RNA ... RNA analysis by primer extension. Total RNA was extracted using TRIzol LS reagent (Invitrogen). RNAs were diluted into ... The TRMT1 cleavage fragments exhibit altered RNA binding activity and are unable to rescue tRNA modification in TRMT1-deficient ... First, we tested the interaction between the TRMT1 cleavage fragments and RNA. We have previously shown that TRMT1 exhibits a ...
... results establish a link between tRNA hypomethylation and ANG-dependent tsRNAs formation and unravel m5U54 as a tRNA cleavage ... Besides their canonical roles in translation, tRNAs also originate tRNA-derived small RNAs (tsRNAs), a class of small non- ... coding RNAs with regulatory functions ranging from translation regulation to gene expression control and cellular stress ... tRNA-derived stress-induced RNAs (5′tiRNAs), namely 5′tiRNA-GlyGCC and 5′tiRNA-GluCTC, among others. Additionally, ...
A mammalian cell-based assay for screening inhibitors of RNA cleavage. Methods in Molecular Biology, 540:335 (2009). ... Exogenous control of mammalian gene expression via modulation of RNA self-cleavage. Nature, 431:471-6 (2004). ... RNA, 12:797-806 (2006).. Yen, L., J. Svendsen, J-S. Lee, J.T. Gray, M. Magnier, T. Baba, R.J. DAmato and R.C. Mulligan. ... Recurrent chimeric RNAs enriched in human prostate cancer identified by deep-sequencing. Proc Natl Acad Sci USA 108:9172-7 ( ...
an RNA molecule capable of catalysing a chemical reaction, usually the cleavage of another RNA molecule ...
The transcript cleavage factor paralogue TFS4 is a potent RNA polymerase inhibitor. Nature Communications. 1914, December 2017 ... The CRISPR RNA-guided surveillance complex in Escherichia coli accommodates extended RNA spacers. Nucleic Acids Research. May ... Mechanism of CRISPR-RNA guided recognition of DNA targets in Escherichia coli. Nucleic Acids Research. (30 September 2015) 43 ( ... Mechanism of CRISPR-RNA guided recognition of DNA targets in Escherichia coli. Nucleic Acids Research. 30 September 2015) 43 ( ...
... b Targeting the translation start site of Prdm9 by single-guide RNA (sgRNA). The predicted cleavage site is indicated by a red ... b RNA expression of the PRDM9-interacting proteins in mouse testes (left) and ovaries (right) during meiosis. Data were ... The protospacer adjacent motif (PAM) required for the cleavage is underlined. c. The 26 bp deletion associated with the Prdm9 ... 3a and Supplementary Table 2). According to available mouse RNA-seq data sets (Margolin et al. 2014; Soh et al. 2015), the ...
The mutation enabled a 2-fold increase in the catalytic efficiency of cleavage by renin and a greater than 2-fold increase in ... Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in ... RNA Interference (RNAi)-based therapeutics: delivering on the promise? Annu Rev Pharmacol Toxicol. 2016;56:103-122.. View this ... Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the ...

No FAQ available that match "rna cleavage"

No images available that match "rna cleavage"